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 i 
Abstract 
Trypanosoma cruzi and Trypanosoma brucei are vector-borne protozoan parasites that 
cause devastating disease to humans and livestock in South America, North America 
and Africa.  Both parasites have complex life cycles which involve a variety of different 
environments and nutrient sources within mammalian hosts and arthropod vectors. 
Transitioning between life cycle stages requires a transformation of morphology, 
replicative ability, and metabolism, which requires remodeling of mitochondrial and 
nuclear gene expression. To better understand the complicated genetic factors involved 
in life stage differentiation in these organisms, we have investigated several aspects of 
the regulation of gene expression through life stage transitions. In T. brucei, we 
investigated the role of a putative endoribonuclease, EEP1, on the transition from the 
mammalian life stage to the insect life stage. Our results indicate that EEP1 does not 
play a role in the differentiation process, and may serve an entirely unique function.  In 
T. cruzi, we examined the mitochondrial genome which plays a crucial role in 
metabolism and has been shown to exhibit life-stage specific remodeling in related 
species.  Mitochondrial genome regulation must occur post-transcriptionally in the form 
of RNA editing, translational control, and stability.  Significant changes were detected in 
mature mRNA abundance between several life stages, and these differences appeared 
to be correlated with nutrient availability and replication status.  Overall, both of these 
studies provide further understanding of the regulatory processes that govern life cycle 
transitions in trypanosome parasites. 
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Chapter 1: Introduction 
 The genus Trypanosoma is comprised of parasitic unicellular protozoa, 
characterized by the presence of a flagellum that provides mobility and a kinetoplast, 
shown in Figure 1, that comprises the mitochondrial genome.  Trypanosomes also 
possess several distinct biological characteristics, such as the utilization of a unique 
process of RNA editing and a glycosome, an organelle that serves as the location for 
glucose metabolism (Tielens and van Hellemond 2009).  Although trypanosome species 
share many defining characteristics, they vary greatly in the mechanisms they utilize to 
carry out their life cycle in various hosts and invertebrate vectors.  Trypanosoma brucei 
(T. brucei) and Trypanosoma cruzi (T. cruzi), which will be the focus of this thesis, are of 
clinical importance because they are responsible for diseases that affect millions of 
humans and livestock animals in rural communities around the globe (WHO 2016; CDC 
2017).  T. brucei and T. cruzi share several similarities in their parasitic life cycles.  Both 
carry out life cycle stages within an insect vector before transmission to a host, and are 
able to maintain presence within a mammalian host for an extended period of time, 
evading the host immune system for years before instigating enough damage to cause 
death (Stijlemans et al. 2016; Cardoso, Reis-Cunha, and Bartholomeu 2015).  These 
trypanosome species differ in their specific life cycle and differentiation stages, 
metabolism and energy utilization, and process of pathogenicity in a host. 
 
The Trypanosoma cruzi life cycle and pathogenicity 
  The life cycle of T. cruzi takes place within a hematophagous triatomine insect 
vector (various Triatoma species) and a mammalian host.  The life cycle of this parasite 
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includes three main forms: epimastigotes, amastigotes and trypomastigotes, as well as a 
variety of intermediates (Tyler and Engman 2001) (Figure 2). Epimastigotes and 
amastigotes are replicating life stages, which are able to reproduce asexually via binary 
fission (CDC 2017).  Trypomastigotes are the infective form of the parasite, and can be 
classified as either metacyclic trypomastigotes (insect vector stage) or bloodstream 
trypomastigotes (mammalian host stage).  The life stages of T. cruzi are distinguished by 
their typical position in the parasitic life cycle and morphological characteristics.  As T. 
cruzi proceeds through its life cycle, it experiences major changes in specific gene 
expression and control in the nuclear and mitochondrial genome, which dictate its 
morphology, behavior and metabolic activity in the parasitic process (Pastro et al. 2017; 
Shaw, Kalem, and Zimmer 2016; Li et al. 2016; Berná et al. 2017).   
  T. cruzi parasites replicating in the midgut of the insect vector are referred to 
as epimastigotes.  Epimastigotes are elongated (reaching 30 µm or more in length, 
according to Tyler and Engman 2001) have a visible flagellum emerging from the 
anterior portion of the cell body (Gonçalves et al. 2018), and a kinetoplast located 
anterior to the nucleus (Ferreira et al. 2008).  This life stage subsists on mainly 
carbohydrate and amino acid catabolism (Berná et al. 2017) as the parasites replicate 
and move through the insect’s digestive tract.  When epimastigotes reach the terminal 
portion of the digestive tract, they attach to the rectal wall before differentiating into 
metacyclic trypomastigotes (Kollien and Schaub 2000).  Metacyclic trypomastigotes are 
a highly infective and non-replicative life stage of T. cruzi that will ultimately be released 
in the feces of the triatomine insect (CDC 2017).  
 The T. cruzi insect-stage differentiation process from the epimastigote to 
metacyclic trypomastigote is termed metacyclogenesis. This is an extreme event of 
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transformation, involving changes in morphology, metabolism, surface marker 
expression, and the cease of proliferation (Tyler and Engman 2001).  Factors that trigger 
metacyclogenesis are still unclear, but previous studies support that the process may be 
initiated by nutrient deficiency, cyclic AMP, and adenylate cyclase (Gonzales-Perdomo, 
Romero, and Goldenberg 1988). Tyler and Engman 2001 suggests that the hydrophobic 
interaction of the epimastigote flagellum with the lining of the insect digestive tract may 
prompt a cAMP signal that triggers metacyclogenesis.  A study by Regina C. B Q. et al. 
2000 showed that adhesion itself may be initiated by nutritional stress, as both the 
adhesion and differentiation process was inhibited when nutrients were provided to 
starved T. cruzi cells in vitro. 
  Triatomine insects facilitate the transmission of T. cruzi by taking a blood meal 
from a mammal and defecating near the bite wound.  Feces from an infected insect 
vector contain high levels of metacyclic trypomastigotes, which can infect the 
mammalian host when the human or animal rubs infected feces into the bite wound or 
transmits it into the eyes or other mucosal membranes (Hemmige, Tanowitz, and Sethi 
2012).  Metacyclic trypomastigotes are then able to attach to host cells via extracellular 
proteins, become internalized via a membrane-bound parasitophorous vacuole 
(Fernandes and Andrews 2012) and escape into the cytoplasm by secreting a porin-like 
molecule that facilitates lysis of the vacuole (Andrews 1993).  This attachment and entry 
process requires a considerable amount of parasitic metabolic energy (Barrias, de 
Carvalho, and De Souza 2013). Within the parasitophorous vacuole, T. cruzi receives 
signals that initiate transformation into an amastigote (Li et al. 2016; Tomlinson et al. 
1995) with a rounded cell body 3-5 µm in diameter (Tyler and Engman 2001) and a 
shortened and nearly invisible flagellum protruding from its anterior (Lentini, Dos Santos 
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Pacheco, and Burleigh 2018) (Figure 3).   
  Amastigotes proliferate in the cytoplasm for 3-5 days (Li et al. 2016) before 
differentiating once again to an elongated morphology with visible flagella, bursting 
through the host cell wall, and escaping into the bloodstream or interstitial fluid (Ley et 
al. 1988).  A T. cruzi parasite in this non-replicating extracellular life stage is called a 
bloodstream trypomastigote, and is able to opportunistically invade other types of host 
cells, such as macrophage cells, muscle cells, nerve cells and others or be taken up with 
the blood by a triatomine insect (Van Overtvelt et al. 1999).   Alternatively, replicating 
amastigotes can lead to host cell death, be released from the cell before differentiation 
and proceed to infect additional cells (Walker et al. 2014).  The precise mechanism of 
infection by extracellular amastigotes remains unclear (Walker et al. 2014).  T. cruzi 
amastigotes proliferate within the cell, and can enter a latent phase in which they may 
remain dormant for decades (Teixeira et al. 2011).   
 
Chagas disease symptoms and epidemiology 
  Trypanosoma cruzi infection in humans can cause a variety of pathological 
symptoms.  These manifestations comprise Chagas disease, also known as American 
trypanosomiasis.  The disease has two distinct phases: the acute phase and the chronic 
phase (CDC 2017).  Acute symptoms after becoming infected can be mild or 
asymptomatic, and can include a fever or inflammation around the bite wound or 
membrane that was exposed to the parasite (CDC 2017).  If left untreated, 15 to 30% of 
infected patients will develop chronic Chagas disease, which most commonly affects the 
heart and gastrointestinal tract (Hemmige, Tanowitz, and Sethi 2012).  Chagas 
cardiomyopathy manifests in a variety of conditions, such as arrhythmias, heart blocks, 
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heart failure, thromboembolism, and stroke (Biolo, Ribeiro, and Clausell 2010).  In the GI 
tract, the disease can cause motor disorders that disrupt the digestive process, and can 
also cause dilation of the gastrointestinal tract at different loci (Matsuda, Miller, and 
Evora 2009).  Chronic Chagas disease typically manifests 10 – 20 years after initial T. 
cruzi infection (Sabino et al. 2013). 
 Chagas disease is a neglected tropical disease that affects an estimated total 
of 10 million people in North and South America and has been dubbed by some 
researchers as “the new HIV/AIDS of the Americas” due to a lack of safe and effective 
treatments (Hotez et al. 2012).  T. cruzi is most commonly known to be transmitted by its 
insect vector, but the parasite can also be transmitted through blood transfusion, organ 
transplantation, and from mother to child through vertical transmission (Biolo, Ribeiro, 
and Clausell 2010).  Chagas disease is an important public health issue in rural and 
impoverished populations of Latin America due to its insect vector transmission (Hotez 
et al. 2008).  The symptoms are often overlooked, especially in populations without 
reliable and affordable access to medical care, and the disease disproportionately 
affects people living in poverty (Hotez et al. 2012).  Chagas disease is also a growing 
problem in the United States due to immigration from Latin American countries (Bern 
and Montgomery 2009).  There are an estimated 238,091 US cases of Chagas disease 
as of 2012 (Manne-Goehler et al. 2016), also disproportionately affecting people who 
live below the nation’s poverty line (Hotez 2008).  Current treatment entails an outdated 
drug arsenal, the best of which is only effective during the acute form of the disease and 
causes side effects in a majority of patients (CDC 2017).  A better understanding of the 
pathogenic process, epidemiology, transmission, and biological processes of T. cruzi will 
be essential for the development of better prevention and treatment protocols for 
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Chagas disease. 
 
T. brucei life cycle and pathogenicity 
 The life cycle of T. brucei takes place between the tsetse fly (Glossina spp.) 
insect vector and mammalian host (CDC 2018).  Unlike T. cruzi, T. brucei remains 
extracellular in its mammalian host, inhabiting the bloodstream and tissue fluids (Figure 
4). The extracellular fluids of an infected host contain a pleomorphic (differentiating) 
population of T. brucei parasites, which oscillate between distinct morphology types 
throughout the course of the infection (Barry and Turner 1991). The extremes of these 
morphologies are replicating slender bloodstream forms and nondividing stumpy forms, 
with intermediate stages between the two (Fenn and Matthews 2007).  Slender 
bloodstream cells, which have an elongated morphology, rely entirely on glycolysis for 
their energy supply (Van Grinsven et al. 2009). The host immune system responds to 
the variant-specific surface glycoprotein (VSG) on the bloodstream form parasites, and 
is able to eradicate the majority of the parasite population.  Antigenic variation of the 
VSG surface protein allows a small fraction of cells to evade the defense mechanisms of 
the host (Navarro and Cross 1996).  Replication of these lingering cells will allow a new 
surge of parasitaemia to manifest within the host, dividing through binary fission and 
mostly comprised of replicating slender form cells (Vassella et al. 1997).  As the 
parasitaemia reaches its peak concentration, the population of slender cells is triggered 
to differentiate into shorter, fatter stumpy form cells by a parasite-derived signal called 
the stumpy induction factor (Vassella et al. 1997, Reuner et al. 1997).   
  The tsetse fly becomes infected when T. brucei parasites from the bloodstream 
are taken into the digestive tract of the fly as the insect takes a bloodmeal from an 
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infected host (CDC 2012). Stumpy cells are able to prevail when glucose levels drop 
(Qiu et al. 2018), and are preadapted to survive this and other stresses associated with 
uptake by the tsetse fly vector (Nolan et al. 2000).  Once inside the tsetse fly, the stumpy 
form parasites differentiate into procyclic forms in the midgut (Fenn and Matthews 2007) 
which rely on proline degradation and the TCA cycle for energy production (Mantilla et 
al. 2017), and actively multiply before migrating to the salivary gland.  Throughout this 
journey the parasites undergo a complex differentiation into epimastigotes (Van Den 
Abbeele et al. 1999).  Within the salivary gland, T. brucei epimastigotes attach to the 
epithelium, continue dividing, and undergo another session of differentiation into non-
dividing and highly infective metacyclic trypomastigotes (Kolev, Ullu, and Tschudi 2013).  
Metacyclic trypomastigotes detach and enter the lumen of the salivary glands, (Kolev, 
Ullu, and Tschudi 2013) and from there are transmitted into the bloodstream of the next 
mammalian host through the bite of the tsetse fly (CDC 2018). The insect-stage 
differentiation process of T. brucei differs from the metacyclogenesis of T. cruzi, which 
has just two distinct stages (epimastigotes and metacyclic trypomastigotes) and takes 
place in the hindgut of the insect vector.  The entire insect-stage T. brucei transformation 
process from stumpy form to metacyclic trypomastigote form within the insect takes 20-
30 days (Fenn and Matthews 2007).  
 
African trypanosomiasis symptoms and epidemiology 
  Subspecies of T. brucei are the causative agents of human African 
trypanosomiasis (HAT), also known as African sleeping sickness.  HAT is a neglected 
tropical disease that affects an estimated 50,000-70,000 people in countries throughout 
sub-Saharan Africa with approximately 60 million people at risk (P. G. E. Kennedy 2004, 
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Brun et al. 2010).  HAT is caused by two subspecies of Trypanosoma brucei: T. b. 
gambiense and T. b. rhodesiense.  A third subspecies, T. brucei brucei, causes disease 
in livestock, known as nagana.  T. brucei brucei is sensitive to immune complexes found 
in human blood serum, and therefore is not infective to humans under normal conditions 
(Vanhollebeke and Pays 2010).  Both human and livestock trypanosomiasis have a 
great socioeconomic impact on affected villages, and have been a major reason for rural 
underdevelopment in sub-Saharan Africa (Brun et al. 2010).  As is also the case with 
Chagas disease, the clinical presentation of human African trypanosomiasis is 
complicated, diagnosis is challenging, and the current treatments produce toxic side 
effects in patients (P. G. Kennedy 2013).   
  HAT involves two stages of disease progression: an early hemolymphatic stage, 
and a late meningoencephalitic stage.  In the hemolymphatic stage, the parasites 
proceed through cycles of proliferation in the bloodstream and lymphatic system (P. G. 
E. Kennedy 2004; MacLean et al. 2012).  If left untreated the infection will enter the 
meningoencephalitic stage, in which the parasites cross the blood-brain barrier and 
infect the central nervous system.  This causes an inflammatory reaction in the brain that 
leads to severe neurological symptoms (seizures, sleep disturbances or coma) and 
death in most cases (MacLean et al. 2012).  
   The disease progression of HAT differs between the two causative T. brucei 
subspecies.  The most common form of HAT is caused by T. brucei gambiense, and 
comprises more than 90% of reported HAT cases. This form of trypanosomiasis is more 
prevalent in west and central sub-Saharan Africa (Simarro, Jannin, and Cattand 2008).  
T. b. gambiense causes a chronic infection, which can at first instigate general 
symptoms of fatigue, anemia, weight loss, or weakness (Sternberg and Maclean 2019), 
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or exist in the patient for months to years before detectable neurological symptoms 
develop.  The patient is likely in an advanced stage of central nervous system infection 
when these symptoms start to appear (Simarro, Jannin, and Cattand 2008).  The 
progression of T. brucei gambiense HAT has an average duration of 3 years (Checchi et 
al. 2008).  T. b. rhodesiense causes east African trypanosomiasis, and accounts for 
approximately 10% of HAT cases.  East African HAT is a much more severe and 
quickly-progressing disease, primarily because T. b. rhodesiense is better able to resist 
lysis by normal human serum (Luc Vanhamme and Pays 2004).  East African HAT can 
be fatal within 6 months (Odiit, Kansiime, and Enyaru 1997), and has the potential to 
cause epidemics in human populations (Franco et al. 2014). 
 
Gene expression in Trypanosoma 
  Throughout the life cycles of T. cruzi and T. brucei, the parasites encounter 
contrasting environments within their insect vectors and mammalian hosts.  Variables 
that the parasites will encounter include types and abundance of nutrients available, host 
immune response, oxidative stress, and deviations in temperature, pH, and osmolarity 
(Jimenez 2014).  In order to respond to these environmental changes, the parasites 
undergo extensive alterations in their morphologies and metabolic processes, which 
requires remodeling of the nuclear and mitochondrial genome throughout the organism’s 
life cycle (Tielens and van Hellemond 2009; Jimenez 2014). 
  The regulation of gene expression of both the nuclear and mitochondrial 
genomes is carried out by unique processes in trypanosomes.  Intron-less nuclear DNA 
is transcribed into long polycistronic non-related primary transcripts of up to 100 open 
reading frames by RNA polymerase II (Pol II), which are processed with the 
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concentrated action of trans-splicing and polyadenylation (Michaeli 2011; Preußer, Jaé, 
and Bindereif 2012). The sites and mechanism of the initiation and termination of 
transcription for protein-encoding genes is not well described (Kolev et al. 2010).  In the 
process of trans-splicing, a spliced leader RNA (SL RNA) provides a copy of a common 
39 nucleotide spliced leader sequence to the 5’ end of all mRNA transcripts (Kolev et al. 
2010).  This addition is referred to as a cap 4 structure in trypanosomes, and allows the 
creation of highly stable mRNA products (Perry, Watkins, and Agabian 1987; Palenchar 
and Bellofatto 2006).  Capping is a universal aspect of eukaryotic mRNAs, however, the 
5’ cap is unique and much more complex in trypanosomes in comparison to other 
eukaryotes (Bangs et al. 1992).   
The process in which trans-splicing occurs is also distinct in trypanosomes in that 
it functions together with polyadenylation to process and separate polycistronic 
transcripts (Ullu, Matthews, and Tschudi 1993; Liang et al. 2003).  Ullu, Matthews and 
Tschudi 1993 suggests that addition of a SL RNA sequence cap is a prerequisite event 
for 3’ cleavage and polyadenylation, as the removal of trans-splicing ability in T. brucei 
inhibited the normal formation of the 3’ end.  Machinery of the spliceosome marks the 3’ 
end splice site for cleavage, which is followed by the poly(A) addition (Liang et al. 2003; 
Matthews, Tschadi, and Ullu 1994).  Because of polycistronic transcriptional processes 
in trypanosomes, the regulation of gene expression in trypanosomes operates 
predominantly at the post-transcriptional level (Vanhamme and Pays 1995).  
 
Post-transcriptional regulation 
  Several processes have been described in the post-transcriptional control of 
trypanosome gene expression, including mRNA processing, mRNA degradation and 
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stability, as well as translational efficiency and protein processing (Ouellette and 
Papadopoulou 2009).  The quantity of mRNAs available for translation are determined 
by the efficiency of splicing and by differences in RNA stability (Clayton 2002).  Similar to 
the degradation processes in yeast and mammalian cells, deadenylation of the 3’ 
untranslated region (UTR) by exonucleases was demonstrated in trypanosomes (Haile, 
Estévez, and Clayton 2003).  Bulk degradation is carried out by cytoplasmic 
exonucleases in the 5’ to 3’ direction and in the 3’ to 5’ direction by a complex called the 
exosome.  These actions are stimulated by regulatory proteins that bind to the 3’ UTR 
and lead to rapid degradation of mRNA transcripts (Clayton 2002; Haile, Estévez, and 
Clayton 2003).  Past studies have demonstrated that some RNA binding proteins (RBPs) 
affect RNA abundance by protecting the mRNA from degradation and increasing 
translation efficiency. These RBPs play critical roles in the life stage transitions of 
trypanosomes (Kolev, Ullu, and Tschudi 2014).  The fate of RNA transcripts is regulated 
by interactions between RBPs and protein complexes responsible for translation, editing, 
and degradation (Clayton 2013). 
  Non-encoded 3’ mRNA tails can enlist the actions of exoribonucleases and 
endoribonucleases, which facilitate RNA degradation.  Ribonucleases may also have 
specific roles in RNA processing and turnover, such as the function of TbRND, 
demonstrated by (Zimmer et al. 2011) to have highly specific function in gRNA 
metabolism in T. brucei.   Chapter 2 of this thesis explores the role of the EEP1 
(Exonuclease-endonuclease-phosphatase domain-containing 1) protein of T. brucei, 
which we hypothesized to function as a ribonuclease with actions in RNA degradation 
during developmental transitions. 
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The mitochondrial genome and editing 
  The genome of the trypanosome single mitochondrion is organized within the 
kinetoplast and referred to as kDNA.  kDNA is structured in a complex network of DNA 
rings known as maxicircles and minicircles.  Maxicircles make up approximately 10% of 
the kinetoplast (approximately 50 copies per organelle, 20-40 kb in length) and encode 
small and large subunit ribosomal RNAs (rRNA) as well as a set of essential proteins of 
the electron transport chain on the inner mitochondrial membrane (Schneider et al. 
2001; Feagin 1999).  Minicircles are smaller and more abundant molecules (5,000 to 
10,000 per cell, 0.56 – 2.5kb in length) which contain three or four repeated sequences 
encoding guide RNAs (gRNAs) (Feagin 1999).  Mitochondrial gene expression is a 
cooperative endeavor between both maxicircles and minicircles to produce functional 
mRNA transcripts through the process of editing (Liu et al. 2005).   
  Mitochondrial mRNA (mtRNA) editing is a complex process of post-
transcriptional regulation in which uridine residues (Us) are inserted in or deleted from 
precursor mRNA transcripts in order to develop open reading frames.  Editing takes 
place in 12 of the 20 genes which comprise the maxicircle (Westenberger et al. 2006).  
Akin to nuclear-encoded genes, maxicircles and minicircles are polycistronically 
transcribed (Aphasizhev and Aphasizheva 2014).  gRNAs encoded in minicircles govern 
the specificity of editing by serving as template sequences for endonucleolytic cleavage, 
as well as the insertion and deletion of uridine residues (L. Simpson et al. 2004; Stuart et 
al. 2005).  Partial annealing of the 5’ “anchor” of the gRNA to the initiation site (the site of 
pre-mRNA cleavage) of pre-edited mRNA begins the editing process.  This union 
provides a template for the insertion and deletion of uridine by the multi-protein RNA 
editing core complex (RECC), also known as the “20S editosome,” which interacts with 
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an RNA editing substrate binding complex (RESC) that functions in gRNA binding and 
stabilization (Aphasizheva, Zhang, and Aphasizhev 2016; Stuart et al. 2005; Zimmer, 
Simpson, and Read 2018).  Editing progresses sequentially in a 3’ to 5’ direction along 
the mRNA, and requires the recruitment of multiple gRNA templates (Aphasizhev and 
Aphasizheva 2014) (Figure 5). RNA sequencing studies by Gerasimov et al. 2018 and 
Simpson et al. 2016 provide evidence that the RNA editing process in trypanosomes 
proceeds in a hectic and random manner, potentially resulting in the formation of 
alternative translatable transcripts. 
 
Variations in the mitochondrial transcriptome 
  Research has shown that T. brucei and T. cruzi remodel their metabolic 
processes throughout the course of their life cycles, providing an adaptive mechanism 
that allows them to respond to changing nutrient environments (Tielens and van 
Hellemond 2009; Smith et al. 2017; Barisón, Nakamura, et al. 2017).  Previously in the 
Zimmer laboratory, the T. cruzi mitochondrial transcriptome was examined for changes 
in mitochondrial rRNA and mRNA transcript abundances between two life stages:  
before and after the in-vitro induction of metacyclogenesis.  This study by Shaw, Kalem, 
and Zimmer 2016 uncovered significant variations between transcript abundances in the 
insect life stages, particularly for transcripts encoding proteins of the electron transport 
chain that is responsible for cellular respiration.  Chapter 3 of this thesis continues this 
work, focusing on variations in mitochondrial transcripts between the insect life stages 
and the intracellular amastigote stage of T. cruzi. 
 
 14 
Chapter 2: The Role of EEP1 in Trypanosoma 
brucei 
 This chapter is focused on the possible role of a protein factor during culture 
differentiation that mimics the transition from the T. b. brucei slender bloodstream form 
(BF) of the mammalian host, to the procyclic form (PF) parasites in the tsetse fly vector.  
Developmental events in T. brucei include modifications in morphology, metabolism, 
gene expression, protein synthesis, and signaling pathways (Fenn and Matthews 2007).  
Many of the underlying mechanisms behind these changes are not well understood, 
therefore, discovery of the roles that specific proteins play in T. brucei differentiation is 
important.  This chapter describes our investigation of the role of EEP1, a nuclear-
encoded protein that potentially functions in RNA degradation.  We have examined the 
effects of EEP1 overexpression and silencing on the differentiation process described 
above.   
 
Preliminary investigation of EEP1 function  
  As mentioned in Chapter 1, trypanosomes control the expression of protein-
encoding genes by means of several posttranscriptional mechanisms, one of which is 
selective mRNA degradation (Clayton 2002).  In general, various RBPs bind with mRNA 
to form messenger ribonucleoprotein (mRNP) complexes and determine the fate of the 
mRNA after it is exported from the nucleus to the cytoplasm, where it can be either 
translated, silenced, or degraded (Cassola 2011).  mRNP complexes are believed to be 
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remodeled as soon as they enter the cytoplasm in other eukaryotes, but there is little 
information about how this process ensues in trypanosomes (Cassola 2011). 
The EEP1 sequence in T. brucei is similar to human PDE12, which is a 
deadenylase. PDE12 has been shown to remove poly(A) tails from mitochondrial 
mRNAs, and serves as an important regulator of mitochondrial protein translation 
(Rorbach, Nicholls, and Minczuk 2011).  The sequence resemblance to PDE12 points to 
EEP1 having a nucleolytic function in trypanosomes.  Actually, analysis done by the 
Zimmer and Laurie Read labs (2011-present) found that EEP1 was an endoribonuclease 
in vitro.  These laboratories found preferred endonuclease cleavage sites for 
recombinant EEP1 within a substrate RNA oligomer, and found that the enzyme is only 
active on RNA.  In sum, the idea that EEP1 functions as a ribonuclease in T. brucei cells 
is supported. 
  Additional Zimmer and Read laboratories’ unpublished studies provide more 
details about EEP1.  It appears to be localized mainly in the cytosol, indicating that 
EEP1 must function differently in trypanosomes than PDE12 in humans, which is a 
mitochondrial enzyme.  Processing bodies (P bodies) are conserved complexes 
localized in the cytosol of trypanosomes and other eukaryotes that contain enzymes 
known to be involved in mRNA turnover (Cassola 2011).  Preliminary co-localization 
studies investigated the potential association of EEP1 with P bodies in T. brucei, and 
found that EEP1 did not localize in P bodies (Figure 6). The assay visualized the 
localization of overexpressed EEP1 and constitutively expressed mCherry-labeled 
SCD6, a component of all P-bodies (Buchan, Nissan, and Parker 2010).  This indicated 
that EEP1 is not likely acting in the major canonical mRNA storage and decay pathways, 
and may instead target specific RNAs.  
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 Finally, EEP1 was found to be developmentally regulated at the protein level.  
EEP1 mRNA is present at equal abundances in the T. brucei bloodstream form and 
procyclic form, but the protein is only present in the procyclic form (Figure 7).  The life-
stage dependent presence of EEP1 indicates that there is a BF stage translational block 
to EEP1 expression, which is a common phenomenon in trypanosomes for appropriate 
life-cycle stage transitions (Romaniuk, Cervini, and Cassola 2016).  
 
Hypothesis: We predict that EEP1 has a functional role in the T. brucei 
differentiation process because of the above preliminary results and the results of 
a genome wide RNAi screen. 
  An RNAi screen by Alsford et al. 2011 used an RNAi plasmid library containing 
randomly cut genomic fragments to create an inducible library of bloodstream form T. 
brucei. This study aimed to uncover genes that potentially provide essential functions 
throughout life cycle transitions. Alsford et al. 2011 screened for the disappearance of 
fragments within the RNA silencing construct in populations of trypanosomes that carry 
the RNAi library before and after RNAi induction (Figure 8). Upon analysis of DNA 
isolated from induced and uninduced cell populations growing and differentiating to 
procyclic form in vitro, they reported that populations surviving post-differentiation 
showed a 3-fold over-representation of the presence of the silencing construct 
containing EEP1 sequence. This implies that a deficit of this protein potentially results in 
a gain of function during the differentiation process.  In this study, we aimed to explore 
the potential effect of EEP1 silencing and overexpression on T. brucei differentiation 
rates, which would provide more insight into the function of EEP1.  
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Methods  
T. brucei cell culture and differentiation 
The T. brucei brucei SingleMarker (SM) bloodstream form (BF) cultures were maintained 
in HMI-9 medium with 10% FBS, in a humidified 5% CO2 incubator at 37°C.  Cultures 
were diluted approximately 1 to 25 every 2-3 days.  Differentiation of T. brucei from BF 
to PF was accomplished by resuspending exponentially growing T. brucei BF cells in 
HMI-9 medium supplemented with 6mM citrate/cis-aconitate (CCA), adjusting the pH 
back to 7.5, and lowering the temperature to 27°C (Szöor et al. 2013).  Numbers of cells 
in the differentiating cultures were counted every 24 hours.  Cells were collected for 
analysis at indicated timepoints (Figure 9) by centrifugation of 1.5-2.5 ml of culture, 
which was resuspended in 1 ml flow cytometry (FACS) buffer (20 ml 0.5 M EDTA, 2.5 g 
BSA, 50 ml 10X PBS, 380 ml H20) and 500µl 8% paraformaldehyde (PFA).  At the 48 
hour timepoint, the remaining culture was centrifuged and resuspended in 10ml SDM-79 
base differentiation medium with 6mM CCA, 10% FBS, 1% penicillin-streptomycin, and 
pH adjusted back to 7.5.  Cultures were counted and 1.5-2.5 ml was collected every 24 
hours for the following 48 hours (total differentiation time: 72 - 96 hours).  Statistical 
variation of cell concentration during differentiation was determined using a 2 way 
ANOVA (Tukey’s multiple comparisons test) comparing column means, alpha = 0.05. 
 
Transfection and induction of EEP1-OE and EEP1-RNAi plasmids 
  pLEW100EEP1-LSH (denoted hereafter as EEP1-OE) and p2T7-177EEP1 
(denoted hereafter as EEP1-RNAi) plasmids were generated previously by the Read lab.  
These plasmids were purified and digested with Not1 restriction enzyme for 
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electroporation into T.b.b. BF (SM) cells to generate stable transfectants (plasmids are 
integrated into the genome at specific locations). Parent plasmids are described in 
(Scahill, Pastar, and Cross 2008) and (Wickstead, Ersfeld, and Gull 2002). For 
transfection, BF(SM) cells were grown to confluence in HMI-9 and 5´107 cells were 
centrifuged at 1000xg for 10 minutes.  Supernatant was removed completely and cells 
were resuspended in 100ul of TB-BSF buffer (90 mM NaP04 pH 7.3, 5 mM KCl, 50 mM 
HEPES pH 7.3, 0.15 mM CaCl2). 10µg of linear plasmid was added, transferred to a 
transfection cuvette, and transfected at Nucleofector II (Lonza) setting Z-001. Cells were 
transferred to 125ml HMI-9 medium and left in the 37°C incubator for approximately 18 
hours, after which 2.5µg/ml phleomycin was added for EEP1-RNAi cultures, and 0.1 
µg/ml puromycin for EEP1-OE in order to select for cells that had incorporated the 
selectable marker specific to each plasmid. Control cultures were transfected according 
to the same protocol, but with an equal volume of water in place of the plasmid.  These 
lacked any selectable marker and died within 2-5 days post-transfection. Transfected 
cell lines were verified via PCR on extracted DNA with appropriate primers for plasmid 
sequence detection as described in results. (EEP1-OE EEP1-LSH fwd: 5’ CGA GAA 
CGA TCA TCA CCA TCA 3’.  LSH plasmid rev: 5’ TCC AAA GCA AAC ATG CAG ATT 
C 3’).  EEP1-RNAi primer: Phleo_w_Xbal: 5’ AAA TAA GCT CTA GAA TGG CCA ATG 
TGA CCA GTG C 3’. Phleo_w_PsH: 5’ ACC AAC CTG CAG TCA GTC CTG CTC CTC 
GGC 3’.  PCR products were evaluated on a 1% agarose gel run at 130 V. 
  Both EEP1-OE and EEP1-RNAi cell lines were induced for expression with 
2.5µg/ml tetracycline.  Tetracycline was added in advance of experiments comparing 
differentiation under differing amounts of EEP1: 24 hours prior for EEP1-OE and 48 
hours prior for EEP1-RNAi. For experiments optimizing EEP1 cDNA expression, RNA 
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was isolated from cell lines in TriPure (Roche TriPure Isolation Agent). DNA was 
digested from RNA samples using a DNAfree kit (Life Technologies). cDNA was 
synthesized from total RNA with Omniscript RT kit (Quiagen), amplified by PCR with 1.5 
µM forward and reverse primers (EEP1-LSH fwd: 5’ CGA GAA CGA TCA TCA CCA 
TCA 3’.  LSH plasmid rev: 5’ TCC AAA GCA AAC ATG CAG ATT C 3’).  PCR products 
were evaluated on a 1% agarose gel, run at 130 V. For quantitative RT-PCR (qRT-
PCR), DNase digested RNA was used to synthesize cDNA with random hexamers and 
TaqMan Reverse Transcriptase (Applied Biosystems).  RNA abundances were then 
quantified from samples through qRT-PCR, using LightCycler equipment and software 
(Roche LightCycler480 Version 1.5.0.39).  Samples were quantified using absolute 
quantification/second-derivative maximum, as in Shaw, et al. 2016 fitted to a standard 
curve of five 4-fold serial dilutions of cDNA, and normalized to Telomerase Reverse 
Transcriptase (TERT).  Amplified sequence was within the coding region of EEP1, near 
the 5’ non-encoded region of the transcript. (Tb927.2.2430 for (47-164) 5’ GTG CCA 
TTA TCA CTT TGG AC 3’; Tb927.4.2430 rev (47-164) 5’ CTA AGT CGC TCA ATT GCT 
CT 3’).  This amplification measured both endogenous and exogenous EEP1 mRNA 
levels. 
 
Antibody tag and flow cytometry 
  T. brucei BF (SM) PFA-fixed cell samples from indicated timepoints throughout 
the differentiation protocol were centrifuged at 1000xg and resuspended in primary 
antibody at 1:20,000 dilution in FACS buffer for the EP procyclin analysis (primary 
antibody: rabbit-derived anti-EP procyclin, gift from Jay Bangs laboratory). For the VSG 
analysis, primary antibody was diluted 1:5,000 in FACS buffer (Primary antibody: rabbit 
 20 
derived anti-VSG221, gift from Jay Bangs laboratory). Cells were incubated with primary 
antibody at RT for 45 minutes, rinsed once with 1 ml FACS buffer, centrifuged and 
resuspended in secondary antibody (Alexa Fluor 488 goat anti-rabbit IgG; Life 
Technologies) at a 1:200 dilution in FACS buffer.  Cells were incubated with secondary 
antibody at RT for 45 minutes, and washed with 1ml FACS buffer. Sony SH800Z Cell 
Sorter flow cytometry instrumentation was used to detect presence of EP procyclin and 
VSG on cell surface by Alexa Fluor 488 fluorescence.  50,000 – 100,000 events were 
analyzed from each sample, and evaluated with FlowJo version X 10.0.7r2. 
 
Western blot analysis of EEP1 expression 
  For protein collection, approximately 108 cells of each sample were centrifuged at 
1000 xg and resuspended in 2 parts 1X PBS + 1 part 4X SDS loading buffer (40% 
Glycerol, 240 mM Tric/HCl pH 6.8, 8% SDS, 0.04% bromophenol blue, 5% beta-
mercaptoethanol).  Samples were heated to 95°C for 5 minutes and stored at -20°C.  
Samples were run on 7.5% acrylamide gel at 35 mA, and transferred to nitrocellulose 
transfer membrane at 55 mA for 50 minutes.  Membrane was covered with TBS (Tris-
buffered saline (50 mM Tris-Cl, pH 7.6; 150 mM NaCl) containing 0.05% Tween + 5% 
milk for 1 hour at RT, and incubated with primary antibody (Antigen Purified EEP1 #81 
Bleed 1 51112) at 1:300 dilution with 1% milk for 12 hours at 4°C.  Primary EEP1 
antibody was rinsed in fresh TBS-Tween three times for 5 minutes, 10 minutes, and 15 
minutes each.  Membrane was incubated with secondary antibody (800 CW-conjugated 
goat anti-rabbit IgG; LI-COR Biosciences) diluted 1:5000 in 1% milk for 1 hour at RT.  
Secondary antibody was rinsed in fresh TBS-Tween three times for 5 minutes, 10 
minutes, and 15 minutes each. Gel was imaged with LI-COR instrumentation at 800CW 
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for 10 minutes.  
 
Growth assays comparing EEP1-OE and EEP1 RNAi bloodstream form cell lines 
  T.b.b. BF cell lines containing the EEP1-OE plasmid and the EEP1-RNAi plasmid 
were cultured at 5´103 cells/ml.  Each cell line was cultured with 3 replicates induced 
with tetracycline at 2.5µg/ml (+TET), and 3 replicates containing no tetracycline as a 
negative control (-TET).  Cultures were grown in HMI-9 and kept in 37°C incubator.  
Parasite concentration was counted in each culture every 24 hours for 6 days, with 
dilution in fresh medium to original concentration every 48 hours.  Statistical differences 
were compared using linear regression analysis, and significance was determined using 
alpha = 0.05. 
 
Results 
Creation of EEP1 silenced and overexpressed T. brucei cell lines 
  RNA interference (RNAi) has been shown to be an exceptional tool for use in 
functional analysis of T. brucei gene products.  The presence of an endogenous RNAi 
pathway sets T. brucei apart from T. cruzi, as the latter lacks requisite components of 
the pathway (Subramaniam et al. 2006).  In the tetracycline-induced RNAi system we 
used to silence EEP1, tetracycline is used to enable double-strand RNA (dsRNA) 
synthesis and generate a population of heterogeneous small interfering RNAs (siRNAs) 
that specifically silence the corresponding mRNA (Alsford et al. 2011).  
 Dr. Zimmer previously created EEP1-OE (also possessing a linker-strep-histidine 
C-terminal tag) and EEP1-RNAi plasmid constructs for her generation of PF cell lines for 
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overexpression and silencing (not used in this study). Inducible EEP1-OE and EEP1-
RNAi BF cell lines were required for experiments testing the impacts of EEP1 
abundance on BF to PF differentiation. These were generated in vitro and verified for 
presence of the desired construct by electrophoresis of DNA isolates amplified by PCR 
(Figure 10).  Primers were specific for the LSH segment occurring behind the EEP1 
sequence in the EEP1-OE plasmid (Figure 11).  For the EEP1-RNAi plasmid, primers 
amplified the phleomycin resistance gene.  These results show that the plasmids were 
successfully integrated into the T. brucei genome for both cell lines.  
  As with BF T. brucei EEP1-RNAi cell lines, EEP1-OE cell lines require induction 
with tetracycline in order to overexpress EEP1.  In order to proceed with experimenting 
on our newly-created cell lines, we needed to know when each induced cell line 
exhibited pronounced changes (either depletion for silencing or increases for 
overexpression) in EEP1 mRNA abundances. (Due to the translational block, there will 
be no protein expression to measure). To investigate this, we induced EEP1-OE and 
EEP1-RNAi cell line cultures with tetracycline for 24 and 48 hours and isolated RNA 
from each culture.  RNA from uninduced EEP1-OE and EEP1-RNAi was also collected 
for comparison, as well as that of un-transfected T. brucei BF(SM) cells.  EEP1-OE RNA 
was evaluated for EEP1 plasmid mRNA abundances with the same primer described in 
Figure 11 using RT-PCR, and products were evaluated on an agarose gel (Figure 12a).  
We found that the 24 hour timepoint yielded the largest product band for EEP1-OE 
plasmid expression. EEP1 mRNA abundances in the induced EEP1-RNAi cell line were 
evaluated using qRT-PCR using a primer targeting a sequence of the EEP1 mRNA 
transcript, and found that EEP1 was silenced most prominently at the 48 hour timepoint 
(Figure 12b).  qPCR results for EEP1-OE using the same primer also verified our 
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findings that the 24 hour timepoint showed the most robust overexpression of EEP1 
mRNA (Figure 12b). These data indicate that we successfully generated our requisite 
cell lines and verified that they produce the desired EEP1 mRNA overexpression or 
silencing, at least at the mRNA level, upon induction. Because there is translational 
repression of EEP1 at the BF stage, EEP1 protein expression in any of these cell lines is 
unlikely. 
  Following evaluation of whether our BF EEP1-OE and EEP1-RNAi cell lines 
showed the appropriate up- and down- regulation of EEP1 mRNA levels, we needed to 
verify that upon release of EEP1 translational repression in BF cells, differences in 
abundances at the protein levels would emulate that of the mRNA.  Prior analysis in the 
Read laboratory suggested that release of the translational block should occur as soon 
as BF cells began differentiating (not shown).  After inducing our cell lines with 
tetracycline for the amount of time determined by our optimization process, we then 
differentiated EEP1-OE and EEP1-RNAi BF cell lines to the procyclic form and isolated 
proteins 48 hours into the differentiation process. We found that the induced EEP1-OE 
cell line expressed a larger protein band at the appropriate EEP1 mass of 78.5 kDA, 
compared to the BF(SM) untransfected control (Figure 13). Our induced EEP1-RNAi cell 
line also showed the expected results in comparison to the untransfected cell line: there 
was no trace of the fuzzy, low-intensity EEP1 protein band that appears in the 
differentiated cells without tetracycline.  These results confirmed that our desired cell-line 
phenotypes were created: a greater abundance of EEP1 protein was present in the 
induced EEP1-OE cell line and there was indication of EEP1 silencing in our EEP1-RNAi 
cell line when differentiated to PF. 
 24 
  As a final control measure in our experiment, we had to evaluate whether the 
addition of a plasmid and tetracycline would alter the growth phenotype of our 
transfected cell lines. To evaluate this, we investigated cell proliferation rate by counting 
parasite concentration after three consecutive dilutions in tetracycline induced (+TET) 
and uninduced (-TET) cultures.  We found, as reported in Figure 14, that there was no 
significant difference between the growth rates of +TET and -TET in both the EEP1-OE 
and EEP1-RNAi cell lines, except for the third replicate of EEP1-RNAi. Given the fact 
that EEP1 mRNA is not made into protein in BF, very little change in the growth 
phenotype was the result we expected. The growth analysis confirmed that there are no 
growth effects produced by the introduction or silencing of EEP1 that would complicate 
our analysis. 
 
Evaluation of EEP1 influence on T. brucei differentiation 
  In order to evaluate the potential effects of EEP1 on life-cycle stage changes, we 
differentiated our T. brucei BF cell lines to insect-stage PF cells. The differentiation 
process has been long been known to be induced in vitro by exposure to citrate/cis-
aconitate (CCA) and a reduction of temperature from 37°C to 27°C (Czichos 1986). 
Under these conditions, several distinct changes take place.  The VSG coat is released 
from the cell surface, and the parasites switch their energy metabolism from relying 
entirely on glycolysis (breaking down glucose to several products; predominantly 
pyruvate) to employing a fully functional electron transport chain to undergo oxidative 
phosphorylation (Fenn and Matthews 2007).  As cells transform to the PF life stage, 
VSG is replaced by a completely different surface glycoprotein called procyclin. 
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  Because the Alsford et al. 2011 RNAi screen indicated that the knockdown of 
EEP1 provides an advantage in differentiation, we suspected that we would see this 
reflected in cell numbers through BF to PF differentiation. We hypothesized that 
overexpressing EEP1 would produce a detrimental effect on the differentiation process.  
Typically, during the differentiation process, a certain number of BF cells die, while some 
prevail and successfully differentiate to the PF stage. To evaluate whether EEP1 
expression has an influence on this, we quantified cell death between our EEP1-OE and 
EEP1-RNAi cell lines through the process of differentiation.  Using the differentiation 
protocol described in Methods, we differentiated T. brucei BF (SM), EEP1-OE, and EEP-
RNAi cell lines (transfected cell lines tetracycline induced and uninduced) to procyclic 
form parasites. We found that there was no significant difference between parasite 
numbers in these cell lines throughout the differentiation process (Figure 15).  In 
summary, no growth phenotype or increased death rate during differentiation was 
observed between the EEP1-OE and EEP1-RNAi cell lines.  
  After finding that cell survival in the differentiation process is not altered between 
our EEP1-OE and EEP1-RNAi cell lines, we needed to measure whether there were 
differences in the ability of BF cells to transition to the PF stage.  To assess this, we 
observed the presence or absence of life stage-defined cell surface markers (Procyclin 
and VSG) throughout the differentiation process.  We differentiated induced and 
uninduced EEP1-OE and EEP1-RNAi BF cell lines to PF cells, taking culture samples at 
a variety of timepoints from 0 to 72 hours past the initiation of differentiation.  When 
bloodstream form T. brucei transitions to the insect-stage procyclic form, procyclin 
replaces VSG on the cell surface. We used an AF488-conjugated antibody to detect cell-
surface procyclin (detailed in Methods), and using flow cytometry, we evaluated our cell 
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lines for proportions of cells at each time-point that wield procyclin.  Using a comparison 
to an untransfected T. brucei BF(SM) cell line as our negative control, the results of this 
analysis are described in Figures 16 and 17.  These figures comprise two representative 
trials out of several differentiation experiments that were performed.  Although 
population proportions at each time point varied between replicate experiments, there 
was no difference in the rate of procyclin appearance between the +TET and -TET 
variables in either EEP1-OE or EEP1-RNAi. 
  After assessing T. brucei differentiation rates by observing the presence of 
procyclin, we needed to check whether there would be any difference if we instead 
observed the disappearance of VSG through the differentiation process.  Using our 
EEP1-OE and EEP1-RNAi induced and uninduced cell lines, we used an AF488 
conjugated antibody for VSG to evaluate the presence or absence of VSG at various 
time-points (Figure 18).  We found that there was no difference in the rate of 
disappearance of VSG between any of our cell lines, which corresponds with the results 
from our analysis of procyclin.   
  In summary, we evaluated cell numbers, the appearance of procyclin, and the 
disappearance of VSG throughout the T. brucei differentiation process.  All three of 
these experiments showed that variances in EEP1 protein abundances have no impact 
on BF to PF differentiation.  
Discussion 
This chapter follows up on the preliminary evidence found in a T. brucei genome-
wide RNAi screen that showed potential involvement of EEP1 in differentiating cells.  
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After exploring the effects of varying levels of EEP1 on differentiating T. brucei cells, our 
results do not support our initial hypothesis.  
  RNAi screening can be a powerful tool for functional genomics studies.  
However, important cautions should be considered when interpreting the data from 
these screens, as false discovery can occur due to off-target effects (Mohr and Perrimon 
2012). The Alsford et al. 2011 RNAi screen may have potentially run into sequence-
specific off-target effects that may have produced false positive effects, such as an over-
representation of cells with EEP1 silencing. RNAi methods have also been shown to 
contribute to false negative results, if the RNAi design does not result in an adequate 
knockdown of a target gene (Mohr and Perrimon 2012).  Furthermore, in Alsford et al. 
2011, a different strain of BF T.brucei was used for RNAi library implementation and 
differentiation (T. brucei MiTat 1.2, clone 221a). The differentiation process was also 
slightly different; cells were transferred to glucose-free DTM medium before 
supplementation with cis-aconitate (we kept ours in HMI-9 medium before switching to 
SDM-79 medium). These differences could have potentially uncovered some gene 
expression characteristics that may not develop in our T. brucei BF (SM) strain and 
differentiation protocol. 
   In the case of our EEP1 investigation, EEP1 was decreased 29.2% in the EEP1-
RNAi cell line after a 48-hour induction with tetracycline (Figure 12).  It is possible that 
this degree of knockdown was not robust enough to produce changes in the 
differentiation phenotype.  In future experiments, a knockout design could be applied to 
eliminate the EEP1 gene and completely deplete protein abundances. 
  Preliminary Zimmer and Read lab studies showed that recombinant EEP1 targets 
RNA in vitro.  We are not yet sure what the specific target of EEP1 is, but recent Zimmer 
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lab results (unpublished) have shown that specifically Asp tRNA was degraded more 
rapidly upon EEP1 overexpression in vivo in PF T. brucei.  The effects of EEP1 silencing 
by RNAi were not as dramatic but seemed to show the opposite result on the same 
target.  Future investigations may include studying the influence of cellular EEP1 
abundance on differing RNA targets, such as nuclear and mitochondrial mRNAs, rRNAs, 
gRNAs, snRNAs and various tRNAs. Given the previous unpublished results, I would 
hypothesize that EEP1 function is specific to tRNA degradation. 
 
Chapter 3: Mitochondrial RNA Expression in 
Trypanosoma cruzi 
   
As mentioned in Chapter 1, T. cruzi encounters a variety of different 
environments throughout the course of its life cycle. Previous research endeavors have 
demonstrated that the parasites remodel their metabolic processes in order to deal with 
these changes (Tielens and van Hellemond 2009; Barisón, Nakamura, et al. 2017).  
Nuclear genetic regulation and changes across the life cycle have been investigated by 
many research endeavors, but mitochondrial genome expression has been largely 
neglected by current research efforts.  Because at least 15 of the 20 genes of the 
maxicircle encode subunits for the electron transport chain, evaluating abundances of 
these transcripts throughout the life cycle of T. cruzi will form a solid basis for 
understanding the regulation of mitochondrial protein formation and metabolic 
processes.  Based on the Zimmer laboratory’s previous findings of metabolic and 
transcriptomic modifications within the two insect life stages (Kalem et al. 2018; Shaw, 
Kalem, and Zimmer 2016), the focus of this chapter is the continued investigation of 
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mitochondrial mRNA abundances between the T. cruzi insect life stages (replicating and 
non-replicating) and the replicating intracellular life stage within the mammalian host.  In 
addition, we assessed whether variations in the mammalian host cell type would affect 
mitochondrial RNA (mtRNA) transcript abundances, and compared two different T. cruzi 
strains in our experiments. 
 
The T. cruzi maxicircle 
 There are 20 transcripts encoded in the maxicircle, including 2 encoding 
ribosomal subunits and 15 encoding components of the electron transport chain (Figure 
19).  Three maxicircle transcripts are classified as maxicircle unidentified reading frames 
(MURF) and are titled MURF1, MURF2 and MURF5.  Two ribosomal RNAs are 
encoded, 12S and 9s rRNA, as well as small subunit ribosomal protein S12 (RPS12).  C-
rich region 3 and 4 open reading frames (CR3 and CR4) are also present on the 
maxicircle, the function of which is currently undescribed.  Two duplicate conserved 
element sequences are located upstream of the ribosomal RNA genes.  These elements 
may function as the sites of initiation for replication and polycistronic transcription 
(Westenberger et al. 2006a).   
  This chapter and the work done by Shaw et al. 2016 is focused on 13 maxicircle 
transcripts that are either the organellar rRNAs, encode proteins of the electron transport 
chain that have recognized function in cellular respiration, or are classified as a MURF.  
A complete list of the transcripts evaluated and their corresponding electron transport 
chain proteins are compiled in in Table 1.  Five of this list are required to undergo the 
RNA editing process before translation is possible. 
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Mitochondrial transcript abundance changes during starvation that leads to 
metacyclogenesis 
  Previous studies by Shaw et al. 2016 quantified transcript abundance variations 
that occur during the requisite period of starvation between the replicating epimastigote 
and the non-replicating metacyclic trypomastigote stages of T. cruzi CL Brener (CLB).  A 
nutrient-deprivation medium was used to prompt the process of metacyclogenesis in 
vitro and generate a mixed culture containing metacyclic trypomastigotes and infective 
intermediates.  As presented in Figure 20a, Shaw et al. 2016 recorded a trend of 
increase in abundances of a majority of never-edited transcripts in the infective culture, 
relative to exponentially replicating cells.  As depicted in Figure 20b, little to no change 
occurred in most pre-edited transcript levels during metacyclogenesis, and in contrast, 
there was a significant change in abundances of fully edited transcripts.  The following 
hypotheses outline the aims of the continuation of this transcriptome evaluation, in the 
mammalian host life stage. 
 
Hypothesis 1:  Replicating T. cruzi life stages will show similar patterns of 
mitochondrial mRNA expression. 
  We expected that mtRNA transcript abundances in replicating intracellular 
amastigotes would be observed at levels similar to what was previously recorded in 
replicating epimastigotes, relative to that of the infective culture.  However, we 
anticipated that the results would not be identical between amastigotes and 
epimastigotes, due to the fact that the two replicating life stages inhabit contrasting 
nutrient environments both in vitro and in vivo, and thus utilize different primary 
substrates to generate energy. Studies have shown that intracellular T. cruzi 
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amastigotes utilize glucose or triacylglycerols from their host cells (Gazos-Lopes et al. 
2017; Shah-Simpson et al. 2017) and epimastigotes rely mostly on carbohydrates in 
their exponential growth phase within the insect digestive tract, switching to amino acids 
as glucose levels depreciate (Barisón, Nakamura, et al. 2017). 
 
Hypothesis 2: Sylvio-X10 and CL Brener strains have been shown to be 
metabolically different, therefore, we expect that modifications in the 
mitochondrial transcriptome will be strain dependent.  
  Currently, six classes of T. cruzi groups have been described and classified into 
discrete typing units (DTUs TcI - TcVI) based on geographic distribution and nuclear 
markers. There are also three T. cruzi clades (A, B and C), based on maxicircle gene 
analysis (Westenberger et al. 2006; Ruvalcaba-Trejo and Sturm 2011; Brisse, Dujardin, 
and Tibayrenc 2000). CLB is a hybrid strain of Clade B and DTU TcVI and Sylvio X10 
(SYL-X10) is of clade A and DTU TcI (Zingales et al. 1997; Ruvalcaba-Trejo and Sturm 
2011). Comparatively, the strains have substitutions and indels in maxicircle transcripts 
encoding protein subunits of the electron transport chain (Ruvalcaba-Trejo and Sturm 
2011).  Recent studies in the Zimmer laboratory (Kalem et al. 2018). have shown that 
there is variability in important mitochondrial characteristics between T. cruzi strains, 
including mitochondrial membrane potential, mitochondrial morphology, acidic metabolic 
byproduct excretion, and maximal respiratory capacity.  Strain-specific variations were 
also revealed using high-throughput RNA sequencing of the total genome, specifically in 
abundances of mRNA transcripts encoding proteins with important metabolic functions 
(Kalem et al. 2018).  We expected that mitochondrial mRNA abundances would show 
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variations in life-stage transition trends between T. cruzi SYL-X10 and CLB strains. 
 
Hypothesis 3:  The type of mammalian host cell infected by T. cruzi will impact 
mitochondrial mRNA expression in the amastigote life stage. 
 As mentioned in Chapter 1, T. cruzi amastigotes in the acute stage of Chagas 
disease multiply profusely within host cells.  In a chronic T. cruzi infection, repressed 
translation gives rise to latency of amastigotes within host cells, which can ensue 
asymptomatically for decades (Teixeira et al. 2011).  To investigate the effect of host cell 
type on the T. cruzi mitochondrial transcriptome, we used two different forms of host 
cells to generate amastigotes in vitro.  To mimic a typical cell infected during the acute 
infection, we used fibroblasts, and to represent the chronic stage of infection, we used 
cardiomyocytes.  We predicted that transcript abundances would show a general trend 
of being reduced in the cardiomyocyte host cells in comparison to fibroblast host cells. 
 
Materials and Methods 
T. cruzi culture and mammalian cell infection 
The T. cruzi CL Brener (generously provided by the DoCampo lab, University of 
Georgia) and Sylvio X10 (ATCC® 50823) strains were maintained in liver infusion 
tryptose (LIT) medium with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin 
at 27°C and 5% CO2.  Epimastigotes in exponential-phase growth were diluted with 
fresh LIT every 2-4 days.  To induce metacyclogenesis, 1 ml of exponential-growth 
phase T. cruzi in LIT were added to 10 ml of Roswell Park Memorial Institute Medium 
(RPMI) and incubated at 27°C for 8 days.  To obtain metacyclic trypomastigotes, the top 
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7ml fraction of 8-day RPMI culture was collected and T. cruzi parasite concentration was 
counted for use in mammalian cell infection assays. 
Two mammalian cell lines were used for infectivity assays to procure T. cruzi 
amastigotes: human cardiomyocyte line AC16, maintained in Dulbecco’s Modified 
Eagle’s Medium (DMEM)/F-12 with 12.5% FBS and 1% penicillin-streptomycin, and 
murine fibroblast line 3T3-L1, maintained in DMEM with 10% FBS and 1% penicillin-
streptomycin.  Mammalian cells were cultivated by weekly passage and incubated at 
37°C in 5% CO2. 
  For infectivity assays (timeline shown in Figure 21) fibroblast cells were plated in 
6-well plates at 5x104 per well, in DMEM + 10% fetal bovine serum (FBS) and incubated 
at for 24h at 37°C, 5% CO2.  Cardiomyocytes were plated at 2.5 x 104 per well, in 
DMEM/F-12 + 12.5% FBS and kept for 24 hours at 37°C in 5% CO2.  Medium was 
removed and replaced with warm DMEM + 2% FBS medium.  Cells were infected with T. 
cruzi parasites from top fraction of 8 day RPMI culture at a multiplicity of infection (MOI) 
of 100 parasites per mammalian cell for SYL-X10 infectivity assays, and an MOI of 200 
parasites per mammalian cell for CL Brener infectivity assays.  Infected mammalian cells 
were incubated for 24 hours at 37°C, after which extracellular T. cruzi were removed 
from the mammalian cell medium by rinsing 5X with warm DMEM + 2% FBS.  
Remaining mammalian cells were incubated for an additional 48 hours.  Mammalian 
cells were then rinsed with DMEM + 2% FBS medium to remove any remaining T. cruzi 
before RNA isolation and staining. 
  Nutrient-starved cells were generated by resuspending exponential growth phase 
T. cruzi SYL-X10 in TAU at 1´107 cells/ml and incubating at 27°C for 48 hours. 
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Staining and microscopy 
  At the time of RNA collection, 1-2 wells of T. cruzi were dried and fixed with 
100% methanol, and permeabilized with 1 ml IF-PERM per well for 15 minutes at RT.  At 
indicated timepoint, 1 ml buffer for Giemsa by Soerensen (17.5 ml 9.08g/L KH2PO4 , 82.5 
ml Na2HPO4 anhydricum, pH 7.45.) and 500ul Wright Giemsa stock solution (Ricca 
Chemical Company, Giemsa Stain Stock Solution) were added, swirled to mix, and left 
for 30 minutes at RT.  Stain was removed and cells were rinsed thoroughly with water.  
Stained cells were covered with water and photographed at 400X. T. cruzi intracellular 
amastigote quantification was determined by counting 100 mammalian cells in each of 3 
replicates.  Statistical analysis was performed to determine differences in number of 
cells infected and number of amastigotes per cell using 2 way ANOVA, alpha = 0.05. 
T. cruzi 8 day RPMI culture used for mammalian cell infection was fixed on a 
microscopy slide with 100% methanol and stained with 3% Giemsa by Sorensen (as 
indicated above) for 20 minutes and rinsed with water.  Slide was viewed at 600X and 
photos were taken for quantification of metacyclic trypomastigotes.  Metacyclic cells 
were identified by the kinetoplast located completely posterior to the nucleus (Shaw, 
Kalem, and Zimmer 2016) (Figure 1).  Cells were quantified manually using a cell 
counting program: NIH ImageJ64 1.47v.  A minimum of 100 cells were counted for each 
of 3 replicate cultures, and analyzed for strain-specific differences using an unpaired t 
test, parametric, with alpha = 0.05. 
 
RNA isolation and semi-quantitative RT-PCR 
  T. cruzi infected mammalian cells in 4-5 wells were lysed directly in TriPure 
(Roche TriPure Isolation Agent) for RNA isolation.  A similar quantity of uninfected cells 
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from both cell lines were lysed with TriPure to be used as uninfected control RNA.  DNA 
was digested from RNA samples using a DNAfree kit (Life Technologies). cDNA was 
synthesized from total RNA with random hexamers and TaqMan Reverse Transcriptase 
(Applied Biosystems).  RNA abundances were then quantified from samples through 
qRT-PCR, using LightCycler equipment and software (Roche LightCycler480 Version 
1.5.0.39).  Samples were quantified using absolute quantification/second-derivative 
maximum, as in Shaw et al. 2016, and fitted to a standard curve of five 4-fold serial 
dilutions of cDNA.  Samples were from three biological replicates, collected on different 
days, and measured in duplicate wells.  Primer sequences are listed in Table 2. 
Statistical differences between life stages were quantified using a ratio paired t test 
(amastigotes vs. infective culture, amastigotes vs. exponentially growing epimastigotes); 
alpha = 0.05.  Statistical differences between amastigotes in cardiomyocytes and 
fibroblasts was calculated using parametric unpaired t tests of relative data (amastigotes 
relative to infective culture or exponentially growing epimastigotes); alpha = 0.05. 
 
Results   
Metacyclic trypomastigotes were quantified in the mixed parasite life-stage 
infection culture in order to optimize the infection protocol. 
Because we used CLB and SYL-X10 parasites for infections, we needed to know 
the proportion of metacyclic trypomastigotes in the top 70% fraction of each 8 day RPMI 
metacyclogenesis culture, which would give us an idea of how many parasites are likely 
infective.  As discovered in Shaw et al. 2016, the top 70% volume of an undisturbed 8 
day RPMI T. cruzi culture contains the greatest percentage of metacyclic 
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trypomastigotes, compared to the fraction of culture beneath, which contains a greater 
proportion of epimastigotes and dead cells. T. cruzi CL Brener and Sylvio-X10 strains 
were incubated in RPMI differentiation for 8 days and the top fraction was sampled and 
stained with Wright Giemsa stain to quantify metacyclic trypomastigotes (details in 
Methods). 
  CLB and SYL-X10 differentiation cultures yielded 14.78% ± 6.871 and 57.32% ± 
20.79 metacyclic trypomastigotes, respectively (Figure 22; an example photograph of 
CLB and SYL-X10 infective culture is shown in Figure 23), which indicated that we would 
likely need to use a higher MOI in CLB infections than in infections with SYL-X10. The 
reported percentage of cells have completed metacyclogenesis with the kinetoplast 
completely posterior to the nucleus.  Some parasites are present in the culture as 
intermediate forms with the kinetoplast in the process of migrating to the posterior 
portion of the cell, and some cells remain as epimastigotes showing signs of starvation, 
which are elongated morphology, shrinkage of the cell body and conical shape at 
posterior end (Gonçalves et al. 2018) (Figure 1, Figure 23).  Proportions of intermediate-
stage parasites and starving epimastigotes were not quantified in our analysis, because 
we currently do not know at which point in metacyclogenesis that the parasites become 
infectious.   
 
Establishment and optimization of a mammalian cell infection protocol was 
required to generate intracellular amastigotes for RNA analysis 
In order to generate intracellular amastigotes in quantities sufficient for RNA 
analysis, we developed T. cruzi strain-specific protocols for mammalian cell infections.  
We optimized infection protocols to generate a maximum number of intracellular 
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amastigotes, while minimizing material from mammalian cells and other trypanosome life 
stages (trypomastigotes and epimastigotes).  Wells from infection assays were stained 
and photographed in order to quantify the number of intracellular amastigotes present 
within mammalian cells under different conditions.  Accurate counts required being able 
to easily designate cell boundaries, so the mammalian cells had to be plated in a way 
that they would not become crowded or overlap.  We performed initial experiments to 
determine the cell plating ranges that would be appropriate for amastigote collection and 
quantification.  We found that cardiomyocytes plated at an initial number of 2.5 x 104 
cells per well would mitigate crowding (Figure 24), and fibroblasts plated at 5 x 104 were 
sufficient to accurately quantify an infection.  Enrichment of mammalian cell medium was 
also adjusted to DMEM+2% FBS (from 10% FBS normal culture medium) in order to 
reduce proliferation of the mammalian cells. 
  Multiplicity of infection (MOI) describes the number of parasites (potentially 
including metacyclic trypomastigotes, epimastigotes, and intermediates) that are added 
per one mammalian cell.  Infections were conducted at a variety of MOI to evaluate the 
optimum for each T. cruzi cell line that would yield the highest percentage of infected 
cells while still maintaining host cell integrity.  For infections performed for RNA 
collection, we chose to use 50-100 parasites per mammalian cell for SYL-X10 infectivity 
assays, and 200 parasites per mammalian cell for assays using CLB because these 
numbers generated consistent percentages of cells infected with amastigotes, as shown 
in Figure 25. 
  After the initial addition of parasites to mammalian cells and subsequent wash, 
the mammalian cells were incubated for an additional 48 hours (72 hours of total 
exposure to the parasites and intracellular parasite growth, as shown in Figure 21).  We 
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observed that if the cells were left for a longer duration than approximately 72-80 hours, 
the T. cruzi parasites would begin to differentiate from amastigotes to bloodstream 
trypomastigotes and burst the mammalian cells. Numerous extracellular amastigotes 
and flagellated parasites was an indication of this occurrence, as well as the presence of 
mammalian cells with intracellular amastigotes in very large numbers (Figure 26).  These 
high amastigote numbers are not ideal for RNA collection, because the populations may 
have exceeded the replicative amastigote stage and started to transition to the non-
replicative bloodstream trypomastigote stage. 
  To quantify the number of amastigotes per cell in our T. cruzi infections, we had 
to develop an effective staining protocol.  After attempting with Wright Giemsa and 
hematoxylin protocols, we found that incubation of methanol-fixed cells with IF-Perm 
before the addition of Giemsa stain was successful in staining the nuclei of mammalian 
cells, as well as the DNA of trypanosomes within the cells. 
 
Variations in intracellular amastigote quantification were found between host cell 
types, but these differences should not create discrepancies in transcriptomic 
data. 
  Because we utilized two different strains of T. cruzi to infect two different 
mammalian cell types, it was important to determine whether the variable of mammalian 
cell type had the potential to create a difference in the number of cells that would be 
infected. To test this, cells infected with T. cruzi were stained and the number of infected 
cells was quantified. Figure 3 shows photographs of typical amastigote infections in 
fibroblasts and cardiomyocytes.  From a total of three biological replicate infection 
assays, the proportion of infected mammalian cells was calculated, and the average 
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number of amastigotes per infected mammalian cell was determined.  Quantifications of 
infectivity assays are reported in Figure 27.  The percent of cells with amastigotes was 
not different between CLB and SYL-X10 in fibroblasts, but was calculated to have a 
significant difference between cardiomyocyte infections (P = 0.0455) (Figure 27a).  
There was no significant difference between the number of amastigotes per cell between 
both T. cruzi strains and host cell lines, which provides evidence that all infections were 
in a similar phase of replication (Figure 27b).  We do not expect that differences in MOI 
or number of cells infected have an effect on our RNA analysis, because at the time of 
RNA collection, all existing amastigotes should be in a replicating phase regardless of 
how efficiently the T. cruzi strain infects host cells.   
 
Specific never-edited and completely-edited mitochondrial RNA transcripts are 
lower in abundance in the T. cruzi CL Brener intracellular life stage in vitro, 
relative to cells incubated in RPMI differentiation medium. 
  We hypothesized that never-edited mitochondrial transcript abundances would 
be lower in the replicating amastigote stage relative to the non-replicating metacyclic 
trypomastigote stage present in 8 day RPMI culture, as they were previously shown to 
be elevated in the infective stage relative to the replicating epimastigote stage (Shaw, 
Kalem, and Zimmer 2016) (Figure 20). To test this in the CL Brener strain, qRT-PCR 
methods were used to quantify the abundance of specific mitochondrial mRNA 
transcripts from T. cruzi intracellular amastigotes and 8 day RPMI infective culture 
containing metacyclic trypomastigotes (hereafter referred to as “infective culture”).  
Quantification of metacyclic trypomastigote percentage of this culture is reported in 
Figure 22.  We examined abundances of two ribosomal mRNA transcripts (9S and 12S) 
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as well as 6 never-edited maxicircle transcripts. Relative to infective culture, several of 
these transcripts were significantly lower in abundance in the amastigote stage as 
compared with day 8 RPMI nutrient-starved cells, and most showed a trend of reduced 
transcript abundances (Figure 28a). The striking exception to this is the MURF5 
transcript.  In previous work comparing mtRNA abundances in epimastigotes to infective 
culture, MURF5 transcript abundance differed very little, if at all (Figure 20).  MURF5 
abundances in CLB were shown to be significantly higher in abundance in amastigotes 
infecting fibroblasts – an unexpected anomaly from the rest of the qPCR data (Figure 
28a).  In general, these data support our hypothesis; never-edited maxicircle transcript 
abundances were generally found to be lower in amastigotes than in the infective 
culture. 
  We predicted that there would be significantly reduced transcript abundances in 
CLB maxicircle completely edited transcripts in the amastigote life stage, relative to 
those of the infective culture.  To test this, we examined qRT-PCR data that utilized 
primers for the pre-edited and edited sequences of four different maxicircle transcripts (8 
primers total). In general, little to no change in abundance was observed in pre-edited 
CLB transcripts, the exception being that of the ATPase-6 (A6) pre-edited transcript, 
which was significantly higher in the amastigote stage (Figure 28b). Edited transcript 
abundances were generally reduced in the four that were tested (CO3-E and MURF2-E 
were significantly different, P < 0.05), the most striking change being the maxicircle 
unidentified reading frame 2 (MURF2) edited transcript.  Our hypothesis was supported 
by these results. 
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CL Brener and Sylvio X10 strain showed similar trends in abundances, with some 
exceptions.     
 Kalem et al. 2018 uncovered notable differences in metabolism and gene 
expression between T. cruzi strains.  In order to investigate whether strain specific 
variation exists in maxicircle transcript abundances, we performed a mitochondrial 
transcriptome analysis on the SYL-X10 strain that was similar to our analysis of the CLB 
mitochondrial transcriptome.  We found that never-edited transcript abundances showed 
similar trends in SYL-X10 as in CLB: the abundances were generally decreased in the 
amastigote stage relative to the infective culture (Figure 28a, Figure 28c).   Another odd 
exception to the trend was the inconsistent MURF5 transcript, which points to the notion 
that MURF5 may not be a viable protein-encoding sequence.  Pre-edited and edited 
sequences showed similar trends: there was little to no change in most pre-edited 
transcript abundances between life stages measured, and a significant downregulation 
of edited transcripts in the amastigote stage (Figure 28b, Figure 28d).  An exception to 
this in the SYL-X10 strain is the CO3 pre-edited transcript, which was found to be in 
significantly higher abundances in amastigotes infecting cardiomyocytes (Figure 28d). 
 In Shaw et al. 2016, T. cruzi CLB strain cells were exposed to nutrient 
deprivation in TAU medium, and abundances of several never-edited and edited 
mitochondrial RNA transcripts were shown to increase in abundance, relative to 
exponentially replicating parasites maintained in LIT.  We performed a similar analysis in 
SYL-X10 in order to explore whether mtRNA transcript abundances would behave 
consistently in a different T. cruzi strain.  Because transcript abundances within the two 
strains behaved similarly in our previous transcriptome analyses, we hypothesized that 
trends in SYL-X10 would be similar to what was observed in CLB.  In Shaw et al. 2016, 
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cells were exposed to TAU starvation medium for 72 hours and analyzed at 8 different 
time-points.  These multiple time-points were unnecessary to duplicate, and in order to 
make our comparison quickly, we exposed our cells to TAU for 48 hours (one time-point 
only). Transcript abundances were significantly higher in starved cells for all never-
edited transcripts, with several (9S, 12S, MURF5, CO1) at 5 to 10-fold the levels of the 
exponentially replicating cells (Figure 29a).  This was shown to be similar in the 12S and 
CO1 levels of CLB. Interestingly, MURF5 abundance levels were shown to be about 7-
fold higher in SYL-X10 after the 48-hour TAU starvation, while only about 2-fold higher in 
CLB after the same treatment. 
  Because we noticed a potentially more pronounced change of mtRNA 
abundances in SYL-X10 life stage changes compared with CLB, we directly compared 
mtRNA abundances from the same life stages in these two strains.  In comparisons of 
infective culture in SYL-X10 relative to CLB, we noticed that there was a general trend in 
elevated abundances of never-edited, pre-edited and completely edited transcripts in the 
SYL-X10 strain, but only one of these data points was found to be statistically significant 
(Figure 30a,c).  In this strain comparison in the intracellular amastigote life stage, there 
were no significant trends indicated in the never-edited transcripts (Figure 30b).  
However, there was a general pattern of higher abundances in the amastigote edited 
transcripts in SYL-X10 relative to CLB, while pre-edited transcripts showed no difference 
between the strains (Figure 30d). 
  mtRNA abundances showed generally similar trends in pre- and completely 
edited transcripts in CLB and SYL-X10 T. cruzi strains, 48-hour TAU starved cells 
relative to exponentially growing cells.  An exception to this is the CO3-P transcript, 
which was shown to be at a much higher in abundance in CLB (48-hour TAU relative to 
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LIT), and was nearly unchanged in SYL-X10 (Figure 29b). Overall, the general trends in 
the never-edited and completely edited transcripts further support our prediction that 
mitochondrial transcript abundances in CLB and SYL-X10 will be altered similarly when 
the parasites are exposed to nutrient deficiency.   
 
mtRNA transcripts in intracellular amastigotes were lower in abundance relative to 
epimastigotes.   
Previous evaluations compared mitochondrial mRNA transcript abundances in 
replicating life stages (intracellular-stage amastigotes and insect-stage epimastigotes) to 
non-replicating infective culture transcript abundances.  We were curious to evaluate 
whether there were any differences in the mitochondrial transcriptome between the two 
replicating life stages.  RNA isolated from exponentially growing T. cruzi SYL-X10 
epimastigotes (three biological replicates) was evaluated using qRT-PCR and compared 
with that of SYL-X10 replicating intracellular amastigotes from cardiomyocyte and 
fibroblast infectivity assays.  Never-edited maxicircle transcript levels were measured, as 
well as pre-edited and completely edited transcript levels. Relative to exponentially 
growing cells, most mRNA never edited transcripts were lower in abundance in 
amastigotes (Figure 31a). Similar to our comparisons of amastigotes to D8 RPMI, fully 
edited transcripts in amastigotes were shown to be at dramatically lower abundances in 
some transcripts (completely edited CO3, CYB, and MURF2) (Figure 31b).  Abundances 
of several transcripts, however, remained unchanged in the pre-edited and fully edited 
mRNA sequence, and in CO3, there were significantly higher abundances of the pre-
edited transcript.  Overall, these results show that there is a general trend of lower 
translatable mtRNA transcript abundances in SYL-X10 amastigotes when compared to 
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insect-stage epimastigotes, revealing a difference in the mitochondrial transcriptome 
between these two replicating life stages.  Based on the previously shown similarities, 
we would expect that CLB transcript abundances would show similar results, but this 
was not tested in this analysis.   
 
Little to no difference in transcript abundance was found between AC16 and 3T3-
L1 cell lines, for both SYL-X10 and CLB amastigotes.  As detailed in the introduction, 
3T3-L1 fibroblasts and AC16 cardiomyocytes were chosen in this experiment to 
represent the acute and chronic stages of T. cruzi infection, respectively. Because these 
trypanosomiasis stages manifest so differently in vivo, we wanted to determine whether 
transcript abundance would contrast between T. cruzi parasites infecting these different 
cell types.  After analysis of relative transcript abundance data from SYL-X10 infections, 
we concluded that transcript levels behaved similarly overall in these mammalian cell 
lines, with a few exceptions.  As pointed out previously, MURF5 abundances of SYL-X10 
amastigotes in AC16 cells were shown to be in significantly higher abundance than in 
3T3-L1 cells.  This was seen both in abundances relative to infective culture (Figure 28c) 
and relative to exponentially growing epimastigotes (Figure 31a). ND2 also showed 
significantly reduced abundances in fibroblasts compared to cardiomyocytes, relative to 
infective culture (Figure 28c).  Pre-edited and edited CYB abundances relative to 
infective culture were significantly higher in cardiomyocytes (Figure 28d). Other 
differences between mammalian cell types were found in the pre-edited CO3, pre-edited 
MURF2 and completely edited CYB transcripts, all of which showed significantly higher 
abundances in the cardiomyocyte infection than in the fibroblast infection, relative to 
exponentially growing epimastigotes (Figure 31b). No significant differences between 
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relative transcript abundances in mammalian cell lines were calculated in the CLB strain. 
 
Discussion 
 This chapter provides evidence for mitochondrial transcriptome alterations 
through the T. cruzi life cycle transition from insect life stages to the intracellular life 
stage within the mammalian host.  To address specific questions we investigated, this 
discussion will be organized by the three hypotheses described previously in Chapter 3 
Introduction. 
 
Hypothesis 1:  Replicating T. cruzi life stages will show similar patterns of 
mitochondrial mRNA expression. 
  This study provides evidence that expression of most never-edited and fully 
edited mtRNA transcripts are similar in replicating epimastigotes and replicating 
intracellular amastigotes.  However, results indicate that there was an even more 
dramatic downregulation trend in the intracellular amastigote life stage relative to the 
non-replicating insect life stage present in the infective culture (Figure 28, Figure 31).  
Mitochondrial mRNA abundances have been shown previously (Shaw, Kalem, and 
Zimmer 2016) to be correlated with the immediate nutrient environment, which may 
include types and levels of nutrients present. T. cruzi epimastigotes replicate 
exponentially in vitro at an approximate concentration of 3.0´107 to 8.75´107 cells/ml, 
according to (Barisón, Rapado, et al. 2017). This is a greatly higher concentration of 
parasites utilizing nutrients than the typical number of amastigotes per mammalian cell 
that we measured, which was less than five amastigotes per cell (Figure 27b Avg. 
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amastigotes per cell).  This variance in parasite concentration may potentially offer 
explanation as to why amastigote mRNA abundances were found to be generally lower 
than those of epimastigotes.  Results from Shaw et al. 2016 showed that when T. cruzi 
had less nutrients available, mtRNA transcript abundances were elevated.  However, it 
is important to note that it would be tremendously difficult to compare the actual nutrient 
levels available to the epimastigotes in LIT to the amastigotes replicating in host cells.  
Overall, the similar patterns we observed in mRNA expression between replicating stage 
T. cruzi provide support for our hypothesis. 
  As pointed out in Results, abundance levels of the never-edited MURF5 
(maxicircle unidentified reading frame) transcript showed divergent alterations through 
life cycle changes relative to patterns shown in other transcripts.  Previously in the 
Zimmer laboratory, the MURF5 DNA sequence was analyzed for start and stop codons 
in the SYL-X10 strain.  Neither of these important elements were found, which suggests 
that MURF5 does not encode a translatable protein product.  The MURF5 sequence was 
found by Ruvalcaba-Trejo and Strum 2011 to have a relatively large number of 
insertion/deletion mutations throughout the gene, and also to overlap 7 nucleotides on 
the 3’ end with the next adjacent maxicircle gene.  Because of these abnormalities, and 
the indications we have found in transcript abundance levels, we can infer that MURF5 
likely does not yield a biologically relevant reading frame.  
  Our transcriptomic analysis provides a quantification of mRNA transcript 
abundances at the very beginning and end of the editing process; we measured pre-
edited mRNA transcript abundances and their corresponding fully-edited transcripts.  
Although this study yields valuable information about editing patterns in different life 
stages, these experiments do not provide any quantification of the intermediate stages of 
 47 
editing.  Experiments in the future may build upon this basis of knowledge with an RNA-
Seq analysis that would delineate the progress of editing at various timepoints in the T. 
cruzi life cycle. 
 
Hypothesis 2: Sylvio-X10 and CL Brener strains have been shown to be 
metabolically different, therefore, we expect that modifications in the 
mitochondrial transcriptome will be strain dependent.  
  Kalem et al. 2018 revealed variations between CLB and SYL-X10 strains in 
extracellular acidification, ATP-coupled respiration, spare respiratory capacity, 
mitochondrial membrane potential, and mitochondrial morphology.  Our study revealed 
that the life cycle-dependent responses of mitochondrial gene expression to life stage or 
environmental stimuli were not divergent from one another, but very comparable. This 
finding does not support our initial prediction.  Potentially, there could be overall 
differences in the quantity of all transcribed products between these strains, but this 
would not be revealed in our data because it was reported as normalized ratios.  When 
we tested SYL-X10 to CLB directly, we found it generally to not be the case.  A single 
exception is the edited mtRNA abundances in amastigotes, which were shown to be 
generally elevated in SYL-X10 relative to CLB (Figure 30d).  Kalem et al. 2018 
experimentally addressed whether there are differences in the number of total electron 
transport chain complexes between T. cruzi strains (analysis of nuclear-encoded 
proteins) and discovered no significant variations. The differences we found in edited 
mtRNA abundances could point to an explanation as to why Kalem et al. 2018 noticed 
distinctions in metabolism between the two strains. Overall, this investigation of 
mitochondrial transcript abundances reveals potential reasons for metabolic differences 
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between CLB and SYL-X10, leaving questions for future research in this area. 
 
Hypothesis 3:  The type of mammalian host cell infected by T. cruzi will impact 
mitochondrial mRNA expression in the amastigote life stage. 
 Very little variation was observed in mtRNA transcript abundances between 
amastigotes in fibroblasts and in cardiomyocytes; therefore, this hypothesis was not 
supported.  A potential limitation to this study is the infection of the host cell lines in vitro, 
within the exact same cell culture medium.  With these circumstances, host cells did not 
experience the typical in vivo environment, stressors, and signaling that might provide 
typical divergent characteristics for these cell types in a living mammalian host.  
Dumoulin and Burleigh 2018 published that the ability of T. cruzi amastigotes to alter 
proliferation rate is an important characteristic of the parasite’s adaptation to 
environmental stressors within the host cell.  This growth plasticity allows the parasites 
to either continue replication in the acute stage of infection (typically within superficial 
cells such as fibroblasts) or slow down their proliferation rate and enter into a latent 
phase in deep organellar cells such as cardiomyocytes.  As revealed in the discussion of 
Hypothesis 1, there is an association between T. cruzi replication status and 
mitochondrial transcript abundance levels. It is possible that our in vitro experiment did 
not provide amastigotes with the appropriate intracellular stressors that would prompt 
them to alter their mitochondrial transcriptome or change their growth rate in these 
different host cell types.  It is also possible that our hypothesis is incorrect; host cell type 
could have very little influence on the induction of gene expression alterations and 
amastigote latency. The intracellular-stage processes could be governed by different 
factors entirely. 
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Summary 
   The experiments in this chapter provide important pieces of evidence in the 
puzzle of T. cruzi mitochondrial transcriptome regulation within specific insect and 
mammalian life stages.  We divulged that regardless of T. cruzi strain or the type of host 
cell infected, the mitochondrial transcriptome follows an established pattern of 
expression across the stages of the life cycle that we investigated.  The final T. cruzi life 
stage remaining to be analyzed for transcriptomic data is the flagellated form that is 
released from the cell to the interstitial fluid or bloodstream of the host: the bloodstream 
trypomastigote.  We predict that because this is an infective and non-replicating life 
stage, it will exhibit mitochondrial transcriptome alterations that are similar to the 
metacyclic trypomastigote infective insect stage.  Overall, the data that we have 
collected may be used as a basis for the continued exploration of the post-transcriptional 
regulatory processes that govern mitochondrial proteins, metabolic function, and host-
parasite interactions within the T. cruzi life cycle. 
 
Chapter 4: Conclusion 
    This body of work details our investigation of some genetic factors involved in 
life-cycle transitions of two important trypanosome parasites: T. brucei and T. cruzi.  
These studies are separate, but related in their focus on the differentiation that occurs 
when the parasites are relocated to a new environment of contrasting temperature, 
nutrient availability, cell density, and other variables.  Environmental factors prompt both 
species of parasites to undergo morphological and metabolic changes, which require the 
remodeling of gene expression.  While my studies each focused on a different 
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mechanism in separate differentiation processes, both examined aspects of post-
transcriptional regulation.  Specifically, we focused on life cycle-specific mature RNA 
abundance and degradation.  As detailed in Chapter 1, stability, maturation, and 
degradation are factors that contribute to the fluctuating changes in gene product 
abundance in trypanosomes. 
    In Chapter 2, we examined the potential influence of a putative 
endoribonuclease, EEP1, on the transition from the mammalian stage T. brucei to the 
insect stage and concluded that it has no influence on the differentiation process.  The 
work described in Chapter 3 measured T. cruzi mitochondrial mRNA abundance 
changes in the differentiation process from insect to mammalian host life stages.  We 
found that in replicating mammalian life stages, mRNA abundances of most 
mitochondrial transcripts are dramatically reduced relative to non-replicating infective 
insect stage parasites.  Furthermore, the T. cruzi mammalian stage mitochondrial mRNA 
levels were comparable to those of the insect replicating life stage, indicating that 
changes in nutrient availability and replication status have a strong influence on the 
expression of electron transport chain components. 
   As in any scientific study, the context of the experiment plays an enormous role 
in the quality of outcome.  The control and acknowledgment of the context of the 
experiment is very important, especially when drawing conclusions.  Our trypanosome 
studies were performed in vitro, using cell lines cultivated in culture flasks for an 
unknown number of previous replication cycles.  In our T. cruzi experiments, a potential 
limitation to our results could be the fact that we are infecting mammalian cells in vitro, 
rather than infecting cells that are part of a live organism.  Follow-up work may include 
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an in vivo investigation of mitochondrial RNA expression in various T. cruzi infected cells 
and tissues, perhaps utilizing a mouse model to generate acute stage infections. 
  The T. brucei BF (SM) cell line we utilized for cultured experiments has a growth 
and differentiation pattern that differs from typical wild type cells but was selected 
because its culture differentiation protocol was well established.  When BF (SM) cells 
proliferate to a high density, they remain in a replicating slender bloodstream form rather 
than differentiating into stumpy cells, as wildtype parasites would do in the bloodstream.   
This anomaly creates a potential limitation to differentiation studies in culture.  If we 
wanted to completely rule out the possibility of EEP1 playing a role in mammalian to 
insect stage differentiation, studies in a cell line that more closely emulates wild type 
behavior may be used to investigate the role of EEP1 and other enzymatic factors 
involved in post-transcriptional regulation.  Because we found no evidence of EEP1 
function in BF to PF differentiation, future directions are likely to proceed to exploration 
of specific EEP1 targets. 
  Much is still unknown about the array of components involved in post-
transcriptional regulation and regulation of the editing process in trypanosomes.  The 
work described in this thesis extends the base of knowledge of post-transcriptional 
processes in both T. cruzi and T. brucei.  These studies give rise to new research 
directions to explore, so that more pieces of information can come together to contribute 
to the overall understanding of genetic processes that are required for the differentiation, 
and thus, the pathogenicity of trypanosome parasites.  When these important genetic 
processes are further exposed, they will be crucial in the development of drug targets 
that may help overcome the enormous public health burdens of African Trypanosomiasis 
and Chagas disease. 
 52 
 
Table 1 Maxicircle primers used for mitochondrial rRNA and mRNA analysis through T. 
cruzi life stages. 
 
 
 
 
 
 
 
 
 
 
 
 
Maxicircle 
sequence name 
Editing required for 
translatable 
mRNA? 
Description 
9S No 9S ribosomal RNA 
12S No 12S ribosomal RNA 
ND1 No NADH dehydrogenase subunit 1 (Complex I) 
ND2 No NADH dehydrogenase subunit 2 (Complex I) 
ND4 No NADH dehydrogenase subunit 4 (Complex I) 
ND5 No NADH dehydrogenase subunit 5 (Complex I) 
CO1 No Cytochrome c oxidase subunit 1 (Complex IV) 
MURF5 No Maxicircle unidentified reading frame 5 
CO2 Yes Cytochrome c oxidase subunit 2 (Complex IV) 
CO3 Yes Cytochrome c oxidase subunit 3 (Complex IV) 
MURF2 Yes Maxicircle unidentified reading frame 2 
A6 Yes ATPase-6 
CYB Yes Cytochrome b (Complex III) 
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Name Forward Primer Reverse Primer TriTrypDB or Source 
TERT SAME AS CLB SAME AS CLB Shaw et al. 2016 
PFR2 SAME AS CLB SAME AS CLB Shaw et al. 2016 
9S SAME AS CLB SAME AS CLB FJ203996.1 
12S SAME AS CLB SAME AS CLB FJ203996.1 
ND1 SAME AS CLB AGCTGGCCCGACTCTAAG FJ203996.1 
ND2 SAME AS CLB SAME AS CLB FJ203996.1 
ND4 CACGTGTGATTACCGGAAATGC TGCTAATACTACACTCATTTCGG FJ203996.1 
ND5 TCTGTTTGGTTTAATATCCGGA GTCAAAAACTTATAAAATGCCTACCTAATA FJ203996.1 
CO1 AAGCCTAGTCACGTCTGCG TAACACCCCCAGCTAGAACT FJ203996.1 
MURF5 GATGTATACAATATGACATTTTTTTG AATGATATTAATGTGTATAGTATTC FJ203996.1 
A6-p CATTTTGCCAAGCTTAGAAGAAA AAAAAATCTCTCCCTTTTACAAAAAGCC FJ203996.1 
A6-e SAME AS CLB ATTTTTTTTTTGTGATTTATTTTGGTTGCG 
Figure S1: 
Ruvalcaba-Trejo 
and Strum 2011 
CO2-p ATTACAGTGTAACCATGTACTCACATT TTCATTACACCTCCCCGGTTCT FJ203996.1 
CO2-e ATTACAGTGTAACCATGTACTCACATT ATTACACCTCCCCGGTATACAA 
Figure S1: 
Ruvalcaba-Trejo 
and Strum 2011 
CO3-P SAME AS CLB SAME AS CLB Shaw et al. 2016 
CO3-e TGTTGTTTATTACTGTGTTGTCCAATATTG SAME AS CLB 
Figure S1: 
Ruvalcaba-Trejo 
and Strum 2011 
CYb-p TAATAAAAAGCGGAGAAAAGAGGAA TCCATATATCCTATATAAACAACCTGACA FJ203996.1 
CYb-e SAME AS CLB TCCATATATCCTATATAAACAACCTGACA 
Figure S1: 
Ruvalcaba-Trejo 
and Strum 2011 
MURF2-p SAME AS CLB CATATAATATATAATCTAAATCAAATCATCAT FJ203996.1 
MURF2-e TAATGTTTTGGTTGTTTTAATTTAGTTTTATT CATATAATATATAATCTAAATCAAATCATCAT 
Figure S1: 
Ruvalcaba-Trejo 
and Strum 2011 
 
Table 2 Primers designed for SYL-X10 qRT-PCR cDNA amplification.  Primers denoted 
“SAME AS CLB” are the same as those used for the CL Brener strain, were designed by 
Dr. Aubie Shaw and are listed in Shaw et al. 2016 supplementary material. 
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Figure 2 The life cycle of Trypanosoma cruzi has stages within a triatomine insect vector 
and mammalian host.  Taken from CDC Public Health Image Library https://phil.cdc.gov 
ID#3384. 
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Figure 3 T. cruzi amastigotes in 3T3-L1 fibroblasts and AC16 cardiomyocytes, stained 
with Wright Giemsa. Small dark spots represent amastigotes, large dark spots indicate 
the mammalian cell nucleus.  Photographs were taken at 400X.  Two strains of T. cruzi 
are represented: Sylvio X10 (SYL-X10, left column) and CL Brener (CLB, right column).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLB	in	cardiomyocytes
CLB	in	fibroblasts
SYL-X10	in	cardiomyocytes
SYL-X10	in	fibroblasts
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Figure 4 The life cycle of Trypanosoma brucei is divided between the tsetse fly vector 
and a mammalian host.  Taken from CDC Public Health Image Library 
https://phil.cdc.gov.  
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Figure 5 Features of the mRNA editing process in trypanosomes.  A gRNA template 
anchors its 5’ anchor region to the mRNA, and guides the insertion and deletion of 
uridine residues, catalyzed by the RNA editing core complex.  Editing proceeds with 
subsequent gRNA templates in a 3’ to 5’ direction.  Reprinted from Read et al. 2016. 
Copyright 2016 Wiley Periodicals, Inc. 
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Figure 12 (A) PCR products of T. brucei cDNA with EEP1-LSH amplification from 
transfected cell line.  DNA from transfected cells was used as a positive control. This 
experiment verifies that there is greater expression of EEP1 mRNA in 24 and 48 hour 
tetracycline induced EEP1-OE cells (+TET 24h, +TET 48h) than uninduced (-TET) 
EEP1-OE cells. Negative controls were untransfected cells (BF (SM) ), no reverse 
transcriptase (-RT) and no RNA (-RNA).  Amplicon is 283 bp.  (B) Reverse transcription 
qPCR results quantifying EEP1 mRNA abundances of tetracycline induced EEP1-OE 
and EEP1-RNAi cell lines relative to uninduced cells.  24 hours and 48 hours post 
tetracycline induction are represented.  Primers are selected from within the EEP1 
coding region.  One biological replicate and two technical replicates were performed. 
These data provides insight as to the timeframe of tetracycline exposure that yields the 
most dramatic overexpression and knockdown of EEP1 mRNA.  
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Figure 16 (1st experiment) Histograms representing flow cytometry analysis of T. brucei 
BF to PF differentiation under TET induced (+TET) and uninduced (-TET) treatments in 
the cell line indicated at the top of the column.  Primary antibody detected the presence 
of cell-surface EP-Procyclin, a PF expressed cell surface marker. Anti-rabbit Alexa488-
conjugated antibody was the secondary antibody.  T.b.b. BF (SM) was differentiated as 
the untransfected control and is shown in comparison to both EEP1-RNAi and EEP1-OE 
results.  One experimental replicate is represented, with 100,000 events analyzed per 
data point.  
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Figure 17 (2nd experiment) Histograms representing flow cytometry analysis of T. brucei 
BF to PF differentiation under TET induced (+TET) and uninduced (-TET) treatments in 
the cell line indicated at the top of the column.  Primary antibody detected the presence 
of cell-surface EP-Procyclin, a PF cell surface marker. Anti-rabbit Alexa488-conjugated 
antibody was the secondary antibody.  T.b.b. BF (SM) was differentiated as the 
untransfected control and is shown in comparison to both EEP1-RNAi and EEP1-OE 
results.  One experimental replicate is represented, with 100,000 events analyzed per 
data point.  
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Figure 18 Histograms representing flow cytometry analysis of T. brucei BF to PF 
differentiation under TET induced (+TET) and uninduced (-TET) treatments.  Primary 
antibody detected the presence of BF-expressed cell-surface VSG.  Alexa488-
conjugated antibody was the secondary antibody. T.b.b. BF (SM) was differentiated as 
the untransfected control and is shown in comparison to both EEP1-RNAi and EEP1-OE 
results.  One experimental replicate is represented, with 50,000 to 100,000 events 
analyzed per data point.   
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CO2 CO3 A6 CYBMURF2
Figure 20 Previously published mitochondrial transcript abundance changes in 
insect-stage T. cruzi parasites.  Transcript abundances measured by qRT-PCR 
fromT. cruzi infective culture containing metacyclic trypomastigotes (nutrient stressed 
in RPMI for 8 days) is shown relative to exponentially growing epimastigotes (Day 0).  
Data points represent mean and SEM, and asterisks (*, P < 0.05; **, P < 0.001) 
represent the results of unpaired t test comparisons.  Taken from Shaw, Kalem and 
Zimmer 2016.  (A) Never-edited mitochondrial transcript abundances. (B) Pre-edited 
and completely edited mitochondrial transcript abundances. 
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Figure 22  Quantification of T. cruzi metacyclogenesis in the differentiated cultures of 
parasites used to infect mammalian cultured cells. Percentage of the total cells in the 
culture found to be metacyclic trypomastigotes are shown for Sylvio-X10 (SYL) and CL 
Brener (CLB) strains.  Error bars represent with SEM. Data point differences are not 
significant, as indicated by an unpaired t test with alpha = 0.05. P = 0.1239.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure___.	Quantifica ion	of	T.	cruzi metacyclogenesis	in	the	
differentiated	cultures	of	parasites	used	to	infect	mammalian	
cultured	cells.		Percentage	of	the	total	cells	in	the	culture	found	to	be	
metacyclic	trypomastigotes are	shown	for	Sylvio-X10	(SYL)	and	CL	
Brener (CLB)	strains.		Error	bars	represent	with	SEM.	Data	point	
differences	are	not	significant,	as	indicated	by	an	unpaired	t	test	with	
alpha	=	0.05.	P	=	0.1239.
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Figure 25 Preliminary quantification of intracellular amastigotes in two mammalian cell 
types (fibroblasts and cardiomyocytes) after infection with infective T. cruzi culture at 
various multiplicity of infection (MOI), the number of parasites added per mammalian 
cell. Data points represent one replicate of each infection; at least 100 mammalian cells 
were quantified for each.  Y-axis represents T. cruzi strain (SYL-X10 or CLB) and MOI.  
Data was used to determine the MOI necessary to produce the most robust T. cruzi 
infections for RNA isolation.  
 
 
 
 
 
 
 
 
 
 
 
Figure	__.	Preliminary	quantification	of	intracellular	amastigotes	in	two	mammalian	cell	
types	(fibroblasts	and	cardiomyocytes)	after	inf tion	with	inf ctive	T.	cr zi	culture	at	
various	MOI.	Data	points	represent	one	replicate	of	each	infection;	at	least	100	
mammalian	c lls	were	quantified	for	 ach.		Y-axis	rep esents	T.	cruzi	str in	(SYL-X10	or	
CLB)	and	number	of	parasites	added	per	one	mammalian	cell.		Data	was	used	to	
determine	the	MOI	necessary	to	produce	the	most	robust	T.	cruzi	infections	for	RNA	
isolation.	
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Figure 28 Mitochondrial RNA abundances in T. cruzi CLB amastigotes, relative to 
infective culture abundances.  Data points represent mean of three replicate infection 
assays, and error bars represent SEM. Relative measurements quantified by qRT-PCR 
and normalized to normalization genes, TERT and PFR. Asterisks (**, P < 0.01; *, P < 
0.05) indicate results of a ratio paired t test in comparison to 8 day nutrient deprivation 
culture. Red brackets represent significant differences (P < 0.05) between transcript 
abundances of amastigotes in fibroblasts and cardiomyocytes, as indicated by an 
unpaired t test.  (A) Relative abundances of never-edited mtRNA transcripts in CLB 
infections of two mammalian cell lines, fibroblasts and cardiomyocytes. (B) Relative 
abundances of CLB pre-edited and completely edited mtRNA transcripts.  Infections 
were performed in fibroblasts only. (C) Relative abundances of SYL-X10 never-edited 
mtRNA transcripts in fibroblast and cardiomyocyte infections. (D) Relative abundances 
of SYL-X10 pre-edited and completely edited mtRNA transcripts in fibroblast and 
cardiomyocyte infections. 
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Figure	___.	Mitochondrial	RNA	abundances	of	RNA	transcripts	in	T.	cruzi	CLB	amastigotes,	
relative	to	infective	culture	abundances.		Data	points	represent	mean	of	three	replicate	
infection	assays	in	two	mammalian	cell	lines,	fibroblasts	and	cardiomyocytes.	Error	bars	
represent	SEM.	Relative	measurements	quantified	by	qRT-PCR	and	normalized	to	
normalization	genes.	Asterisks	(**,	P	<	0.01;	*,	P	<	0.05)	indicate	results	of	a	ratio	paired	t	test	
in	comparison	to	8	day	nutrient	deprivation	culture.	Red	brackets	indicate	results	of	an	
unpaired	t	test	comparing	relative	abundances	in	cardiomyocytes	and	fibroblasts	(P	<	0.05).	(A)	
Relative	abundances	of	never-edited	mtRNA transcripts.	(B)	Relative	abundances	of	pre-edited	
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Figure	___.	Mitochondrial	RNA	abundances	of	RNA	transcripts	in	T.	cruzi	SYL-X10	amastigotes,	relative	to	infective	culture	abundances.		Data	
points	represent	mean	of	three	replicate	infection	assays	in	two	mammalian	cell	lines,	fibroblasts	and	cardiomyocytes.	Error	bars	represent	
SEM.	Relative	measurements	quantified	by	qRT-PCR	and	normalized	to	normalization	genes.	Asterisks	(**,	P	<	0.01;	*,	P	<	0.05)	indicate	results	
of	a	ratio	paired	t	test	in	comparison	to	8	day	nutrient	deprivation	culture.	Red	brackets	represent	significant	differences	(P	<	0.05)	between	
transcript	abundances	of	amastigotes	in	fibroblasts	and	cardiomyocytes,	as	indicated	by	an	unpaired	t	test.		(A)	Relative	abundances	of	never-
edited	mtRNA transcripts.	(B)	Relative	abundances	of	pre-edited	and	completely	edited	mtRNA transcripts.
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Figure 29  Mitochondrial RNA abundances in T. cruzi SYL-X10 TAU starved cells, 
relative to exponentially growing cells.  Data points represent mean of three replicate 
samples. Error bars represent SEM. Relative measurements quantified by qRT-PCR and 
normalized to normalization genes, TERT and PFR. Asterisks (**, P < 0.01; *, P < 0.05) 
indicate results of a ratio paired t test in comparison to exponentially growing cells. (A) 
Relative abundances of never-edited mtRNA transcripts. (B) Relative abundances of 
pre-edited and completely edited mtRNA transcripts. Quantitative RT-PCR performed by 
Sean Faacks, under E. Susa supervision. 
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Figure 30  Mitochondrial RNA abundances in T. cruzi SYL-X10 infective culture and 
amastigotes in fibroblasts, relative to the same CLB life stages.  Data points represent 
the mean of three replicates, and error bars represent SEM. Relative measurements 
quantified by qRT-PCR and normalized to normalization genes, TERT and PFR.  
Asterisks (*, P < 0.05) indicate results of a multiple t tests corrected for multiple 
comparisons by the Holm-Sidak method. (A) SYL-X10 never-edited mtRNA transcripts in 
infective culture relative to that of CLB infective culture. (B) SYL-X10 never-edited 
mtRNA transcript abundances in amastigotes, relative to that of CLB amastigotes. 
Infections were performed in fibroblasts only. (C) SYL-X10 pre-edited and completely 
edited mtRNA transcripts in infective culture, relative to that of CLB infective culture. (D) 
SYL-X10 pre-edited and completely edited mtRNA transcript abundances in 
amastigotes, relative to that of CLB amastigotes. Infections were performed in 
fibroblasts. 
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Figure 31 Mitochondrial RNA abundances in T. cruzi SYL-X10 amastigotes, relative to 
exponentially growing SYL-X10 culture.  Data points represent mean of three replicate 
infection assays in two mammalian cell lines, fibroblasts and cardiomyocytes. Error bars 
represent SEM. Relative measurements quantified by qRT-PCR and normalized to 
normalization genes, TERT and PFR. Asterisks (**, P < 0.01; *, P < 0.05) indicate results 
of a ratio paired t test in comparison to exponentially growing cells. Red brackets 
indicate results of an unpaired t test comparing relative abundances in cardiomyocytes 
and fibroblasts (P < 0.05). (A) Relative abundances of never-edited mtRNA transcripts. 
(B) Relative abundances of pre-edited and completely edited mtRNA transcripts. 
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Figure	___.	Mitochondrial	RNA	abundances	of	RNA	transcripts	in	T.	cruzi	SYL-X10	
amastigotes,	relative	to	exponentially	growing	SYL-X10	culture.		Data	points	represent	
mean	of	three	replicate	infection	assays	in	two	mammalian	cell	lines,	fibroblasts	and	
cardiomyocytes.	Error	bars	represent	SEM.	Relative	measurements	quantified	by	qRT-PCR	
and	normalized	to	normalization	genes.	Asterisks	(*,	P	<	0.05)	indicate	results	of	a	ratio	
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